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ABSTRACT 
Fumonisin B, (FB,) is the most prevalent of the fumonisins, mycotoxins produced by 
fungi of the genus Fusarium that contaminate corn-based foods. Exposure to hazardous 
levels of this mycotoxin has been associated with a broad variety of animal and human 
diseases. Relevant examples are leukoencephalomalacia (ELEM) in horses, pulmonary edema 
and liver damage in swine, and esophageal cancer and neural tube defects (NTD) in humans. 
The efficacy of the fumonisin B-glucose (FB-G) reaction in detoxifying fumonisin B 
(FB) was tested in swine intraperitoneal (IP) and dietary models. The FB-G reaction products 
are obtained by chemically reacting the primary amine group (NH2) present in FB molecules 
with reducing sugars such as glucose through the non-enzymatic browning reaction. In the IP 
model, acute and subacute doses of fumonisin B, (FB,) were administered IP to test the 
efficacy of the fumonisin Br glucose (FB,-G) reaction in detoxifying FB, in swine. In the 
acute IP study at 11 jxmol FBj/kg body weight (BW), five of 6 pigs administered FB, and four 
of 6 pigs administered FB,-G (30% unreacted FB,, 3.3 pmol FB,/kg BW) products died from 
acute pulmonary edema. Analysis of weight gain, serum aspartate aminotransferase and y-
glutamyltransferase, total cholesterol and pathological evaluation did not provide evidence of 
protection against FB, toxicity by the FB,-glucose reaction. This was because these results 
were similar among pigs exposed to either FB, or FB,-G. In the subacute IP study at 5.5 
fAmol FB,/kg BW, one pig administered FB, died from liver damage. Results of serum 
aspartate aminotransferase (AST) (pO.OOOl), y-glutamyltransferase (GGT) (p=0.0002), total 
bilirubin (pcO.OOOl), serum sphinganine (p=0.0009), serum sphinganine/sphingosine (Sa/So) 
ratio (p=0.0216), liver sphinganine (p<0.0001), and liver Sa/So ratio (p=0.0009) as well as 
X l i  
pathologic findings, provided definitive evidence of protection against the FB, toxic effects by 
this detoxification procedure. 
In the dietary model, pigs were fed diets containing 528 pmol total FB/kg, 528 fimol 
total FB-G/kg (23% unreacted FB, 122 gmol total FB-G/kg diet) or 0 pmol total FB/kg for 
15 d to test the efficacy of the FB-G reaction products in detoxifying FB. Weight gain in FB 
pigs was lower than in FB-G (p=0.0001) or controls (p=0.0007), which was correlated with 
feed intake reduction in FB pigs. Serum AST, GGT, and total bilirubin in FB pigs were 
higher than in FB-G (p<0.0001, p=0.0005, and p<0.0001, respectively) or control pigs 
(p<0.0001, pKO.OOOl, and p<0.0001 respectively). Serum Sa/So ratio in FB pigs was higher 
than in FB-G (p=0.05) or control pigs (pO.OOOl). Microscopic examination of tissues from 
FB pigs showed generalized liver necrosis and apoptosis with marked cellular pleomorphism 
and disorganized hepatic cords. Liver and kidneys in FB-G group appeared normal. Tissues 
of controls were free of lesions. The results suggest that dietary FB-glucose products could 
substantially protect swine in instances of widespread FB grain contamination. 
Future research should concentrate on exploring the feasibility of this detoxification 
strategy in swine operations as well as in human food-processing scenarios. Additional work 
is also required to determine if FB-glucose products can inhibit the enzyme ceramide synthase 
in the sphingolipid synthesis pathway, the relationship between this inhibition and the synthesis 
of cholesterol in the liver, and the efficacy of FB-glucose products in preventing ELEM in 
horses and NTD in mice. Finally, the variability on the susceptibility of pigs to FB is worth 
studying. This variability might be the product of genetic polymorphism of the enzyme 
ceramide synthase or differences in FB absorption among different pigs. 
1 
CHAPTER 1. GENERAL INTRODUCTION 
1.1. Introduction 
The purpose of this dissertation was to evaluate the efficacy of the fumonisin B-
glucose reaction products in detoxifying fumonisin B in swine. Fumonisin B, (FBi) is the 
most prevalent of the fumonisins; mycotoxins produced by several fungi of the genus 
Fusarium, in particular F. verticillioides, which contaminate corn crops in the field under 
certain climatic conditions (1, 2). Fumonisin Bi has been referred as the most common 
contaminant of corn and corn-based foods worldwide (3). Its target species include horses, 
rats, mice, rabbits, monkeys, and swine (4), the animal model used in the research studies 
presented in chapters 2 and 3 of this work. Important examples of FBi-induced diseases in 
animal species of economic interest include equine leukoencephalomalacia (ELEM) in horses 
and porcine pulmonary edema (PPE) in pigs (5-7). The International Agency for Research 
on Cancer recently declared FB, as "possible carcinogenic to humans", based on 
extrapolation from studies performed on the carcinogenicity of this mycotoxin in rodents as 
well as in the epidemiological evidence of its involvement on the high incidence of human 
esophageal cancer in South Africa and China, among other countries (8-10). The most recent 
developments in fumonisin research have linked the mycotoxin to neural tube defects in 
children born to mothers consuming diets with high levels of FBi (11, 12), opening a new 
avenue of research in food safety and mycotoxins. The mechanism of action of FB, involves 
the inhibition of the enzyme ceramide synthase in the de novo sphingolipid synthesis 
pathway. The accumulation of precursors of major sphingolipids, such as the sphingoid 
bases sphinganine and sphingosine, is thought to play a key role in the pathogenesis of 
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diseases induced by exposure to the mycotoxin (13-15). Sphingolipids are a major class of 
lipids that serve in eukaryotic cells as important structural molecules in cell membranes and 
as regulators of many cell functions. 
Swine are one of the most sensitive species to FBj, which disrupts the sphingolipid 
metabolism in this species leading to accumulation of sphingoid bases (16). Depending on 
the level of exposure to the mycotoxin, this accumulation may cause liver damage in 
subacute or subchronic cases, or fatal PPE in more acute cases (7, 17, 18). In the early 1990s, 
field outbreaks of FBi toxicosis killed significant numbers of pigs in the Midwest and 
Southeastern parts of the United States, causing significant economic losses (19). 
The general hypothesis of this dissertation was that the products of the chemical 
reaction between FBi (or FB, + FB2) and glucose could eliminate or decrease the toxic 
effects of FB in swine. Two different approaches were taken in this species. The first study 
tested the efficacy of the FB,-glucose reaction products administered intraperitoneal^ (IP). 
The second study was performed by feeding FB-glucose products. The results and 
conclusions obtained from this work will provide swine farmers and food producers in 
general a practical tool that might be used, in future outbreaks of FB toxicosis, to salvage 
corn grain or corn products that are contaminated with FB. An extension of this application 
might be the use of this detoxification strategy to lower FB levels in foods intended for 
human consumption. This could be of special relevance to those regions of the world where 
the consumption of FB-contaminated products is a daily event. 
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1.2. Dissertation Organization 
This dissertation consists of four chapters. The first chapter includes a general 
introduction that was presented before this section, and a literature review. The second 
chapter refers to the first of two research papers, "Glucose reaction with fumonisin B, 
partially reduces its toxicity in swine", which has been accepted for publication by the 
Journal of Agricultural and Food Chemistry. The third chapter refers to the second paper, 
"Fumonisin B-glucose reaction products are less toxic when fed to swine", which will be 
submitted for publication to the Journal of Agricultural and Food Chemistry as well. The 
two papers are written in the format required by the publisher. The fourth and last chapter 
includes a discussion of the conclusions reached and recommendations for future research. 
1.3. Literature Review 
1.3.1. History and discovery of fumonisins 
The fumonisins (FB) are natural toxins or mycotoxins produced by several fungal 
species of the genus Fusarium, plant pathogens that infect corn in the field under certain 
weather conditions. One of the characteristic diseases produced by FB in domestic animals 
was reported in the literature as early as in 1902, when Butler gave a description of 
leukoencephalomalacia after producing the symptoms of the disease in a test horse (20). 
From the work of Butler and others, the causative agent of equine leukoencephalomalacia 
(ELEM) was well understood for most of the 20th century as feed "infected" with species of 
the genus Fusarium (4). Although other cereals such as oats (21) were associated with 
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ELEM, corn was generally recognized as the main source of Fusarium in diagnosed cases of 
the disease. 
Interest in the toxic effects of FB in animals started to increase in the early 1970s as a 
result of ELEM field outbreaks. In 1970, F. verticilloides (Sacc.) Nirenberg (synonym: F. 
moniliforme Sheldon; teleomorph Giberella moniliformis Wineland) was the predominant 
fungus isolated from moldy corn associated with a field outbreak of ELEM in South Africa 
(8). The characteristic lesion observed by Kellerman et al (J), in horses affected by ELEM 
was liquefactive necrosis of the white matter of the cerebral hemispheres. Lesions such as 
bile duct proliferation, increased number of mitotic figures, multinucleated hepatocytes, and 
large, bizarre hyperchromatic nuclei observed in the liver of these animals were considered 
the first evidence of the possible carcinogenic activity of F. verticilloides (19). 
In the early 1980s, human dietary Fusarium exposure was initially linked to 
carcinogenesis when researchers in South Africa became involved in the study of the role of 
fungal toxins in the etiology of human esophageal cancer in the Transkei region, where the 
staple diet is homegrown com (22). Later studies determined that the incidence rate of 
human esophageal cancer in the southern part of the Transkei was among the highest in the 
world (23, 24). Further work done on the toxicology of F. verticillioides MRC 826 isolates 
from field outbreaks of ELEM in horses of the Transkei region found that this isolate could 
cause ELEM experimentally in horses, porcine pulmonary edema (PPE) in pigs, and 
hepatotoxicity and cardiotoxieity in rats (25, 26). Culture material of F. verticillioides MRC 
826 was shown to be hepatocarcinogenic in rats, causing primary hepatocellular carcinoma 
and cholangiocarcinoma (8). 
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While trying to elucidate the identity of the carcinogenic compound synthesized by F. 
verticilloides, Gelderblom et al (9), tested the carcinogenicity of the mycotoxin fiisarin C, 
also produced by F. verticilloides, by performing a short-term initiation/promotion assay in 
rat livers. This assay involved partial hepatectomy of the rats and administration of the 
cancer-initiating compound diethlynitrosamine (DEN), followed by administration of the 
cancer-promoting drug phénobarbital. During the application of the assay, it was found that 
culture material of F. verticilloides MRC 826 initiated the formation of early lesions in the 
liver and exhibited cancer-promoting activity. The fractions of the extracts of culture 
material that selectively stimulated the development of y-glutamyltransferase (GGT)-altered 
hepatic foci (AHF) in rat livers were identified. Finally, in 1988, the mycotoxins fumonisin 
Bi (FBi) and fiimonisin B% (FBz) were isolated from F. verticilloides MRC 826 extracts (9). 
The chemical structures of these mycotoxins were elucidated that same year by Bezuidenhout 
(27). 
The biological activity of a pure form of FBi was further studied in several animal 
species after the elucidation of its chemical structure. Equine leukoencephalomalacia was 
first shown to be caused by purified FBi by intravenous (IV) and oral dosing in 1988 and 
1990, respectively (28, 29). In 1990, PPE was also observed in pigs administered pure FB, 
IV (30), whereas liver cancer was observed in male BDIX rats at a dietary level of 69 jimol 
FBi/kg' (31). 
The natural occurrence of FBi in home-grown corn from the Transkei region of South 
Africa was first reported in 1990 by Sydenham et al (32); along with the publication of the 
1 To convert from p.mol/kg to mg/kg (ppm), multiply amount in pmol by 0.7218 (FBi MW=721.8). 
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first quantitative and sensitive high-performance liquid chromatography (HPLC) method for 
the simultaneous determination of FB, and FB2 in naturally contaminated com and mixed 
feed (33). By using this method, Sydenham et al (34), showed a correlation between the 
levels of FBj and FB2 in home-grown com and the incidence of esophageal cancer in the 
Transkei. What followed triggered a great deal of interest in fumonisin research in the 
United States and worldwide. During the fall of 1989 and the winter of 1990, widespread, 
large-scale outbreaks of ELEM and PPE occurred in the midwestern and southeastern parts 
of the United States. During these outbreaks, significant numbers of horses and pigs died 
from consuming commercial mixed feeds containing FB-contaminated com from the 1989 
com crop (18, 19). 
The next milestone in FB research was achieved when Wang et al (13), reported that 
these mycotoxins could disrupt sphingolipid biosynthesis with the resulting elevation of the 
sphinganine to sphingosine ratio (Sa/So ratio) in serum, plasma or urine of sensitive species 
(35, 36). Since then, the Sa/So ratio has been widely accepted and used as an early 
biomarker of exposure for FB. The development of the Sa/So ratio along with large amounts 
of epidemiological data collected on the carcinogenicity of FB, allowed the International 
Agency for Research on Cancer, in 1993 and 2002, to classify FBi as a group 2B carcinogen 
or "possibly carcinogenic to humans" (37). In the last ten years, FB research has focused on 
the elucidation of its worldwide occurrence, molecular mechanism of action, and 
detoxification strategies. The remaining sections of this literature review will provide an 
insight to those aspects. 
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1.3.2. Worldwide occurrence of fumonisins 
The occurrence of fumonisins in corn crops depends on a variety of environmental 
conditions. These conditions must primarily favor the growth of Fusarium species in the 
corn plant as well as the metabolism of fumonisins by the fungal species. In a review about 
the factors that affect the occurrence of fumonisins, Miller (38) mentioned that one of the 
important Fusarium ear rots of com, Giberella ear rot (F. graminearum, formerly F. 
moniliforme and allied species), grows well only between 26 and 28 °C and requires rain 
both at silking and during disease progression. The review also stated that the fungal species 
that cause Fusarium ear rot (F. verticillioides and allied species) grow at higher temperatures 
and produce FB when exposed to drought as well as insect stress. The growth of com 
hybrids outside their areas of adaptation also favors the growth of F. verticillioides. 
Wherever environmental conditions meet these criteria, infection by Fusarium as well as 
production of fumonisin will be likely in affected com crops. 
Fungi of the genus Fusarium are known to be widely distributed in the world. It was 
not surprising to find worldwide surveys that report the presence of fungal strains capable of 
synthesizing FB. When looking at surveys of FB occurrence, more than noticing the mere 
presence of FB in foods, it is far more important to compare the levels found with the 
maximum levels in human and animal feeds recommended by government agencies such as 
the U.S. Food and Drug Administration (FDA) and other international agencies (Tables 1 and 
2). This is because from a toxico logical point of view, FB levels in foods or feeds that are 
below the current guidance levels are not considered a health threat under the conditions in 
which the guidance levels were established. In general, levels in foods greater than 2.77 
fj,mol total FB/kg of food would be potentially hazardous for humans whereas levels of 7 and 
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Table 1. U.S. Food and Drug Administration current guidance levels for total fumonisins in 
human foods and animal feeds® 
Human Foods 
Product Total Fumonisins (FBt+FB?+FFM 
pmol/kg 
Degermed dry milled corn products (e.g., flaking 2.77 
grits, corn grits, corn meal, corn flour with fat 
content of < 2.25%, dry weight basis) 
Whole or partially degermed dry milled corn 5.54 
products (e.g., flaking grits, corn grits, corn meal, 
corn flour with fat content of > 2.25 %, dry 
weight basis) 
Dry milled corn bran 5.54 
Cleaned com intended for masa production 5.54 
Cleaned corn intended for popcorn 4.15 
Animal Feeds 
Corn and corn-bv products intended for: 
Equids and rabbits 6.92' 
Swine and catfish 27.7= 
Breeding ruminants, breeding poultry and 41.56° 
breeding minkb 
Ruminants > 3 months old being raised for 83.12° 
slaughter and mink being raised for pelt 
production 
Poultry being raised for slaughter 138.54° 
All other species or classes of livestock and pet 13.85° 
animals 
®U.S. FDA, 2001 (39). 
includes lactating dairy cattle and hens laying eggs for human consumption 
cDry weight basis 
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Table 2. Current guidance levels for fumonisins in some human foods from several 
international agencies 
Product Fumonisin concentration (FB, + FB2) 
pmol/kg 
Agency 
Unprocessed corn 3 Scientific Committee on Food 
of the European Union3 
Infant food 0.1 Scientific Committee on Food 
of the European Union" 
Corn 1 Swiss Federal Office of Public 
Healthb 
Cereals 4 Conseil Supérieur d'Hygiene 
Publique de Franceb 
"Scientific Committee on Food of the European Union, 2003 (40). 
bSoriano and Dragacci, 2004 (41) 
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28 gmol total FB/kg of feed will be toxic for animals of economical importance such as 
equine and swine, respectively. In swine, the 28 pmol total FB/kg of feed guidance level was 
established based on pivotal studies for swine by Motelin et al (17), Rotter et al (42) and 
Prelusky et al (43). The no-observed-adverse-effect levels (NOAEL, ppm of FBi + FB2) 
reported by Motelin et al (17) were considered as the basis for the establishment of the 
dietary FB guidance level for swine. These NOAEL were determined using linear regression 
to estimate the lowest FB level which gave an estimated response just exceeding the upper 
95% confidence limit on the FB free control diet. The study included NOAEL for markers of 
liver injury, liver histology changes and weight gain. The lowest NOAEL reported was for 
alkaline phosphatase (ALP, 17 pmol total FB/kg feed), while the highest was for y-
glutamyltransferase (GGT, 51 pmol total FB/kg feed). 
A survey by Nelson et al (44) clearly showed the global occurrence of FB. The study 
reported the occurrence of FBi in com and corn-based foods in 24 countries from four 
continents including Brazil, China, France, Honduras, Hungary, Nepal, Sardinia, South 
Africa and the United States. The highest levels were found in Hungary, 463 pmol/kg; 
Sardinia, 346 pmol/kg, and France, 69 nmol/kg. The lowest concentrations were 
found in Poland and Romania, 42 pmol/kg, and Canada, 69 ^mol/kg. The majority of the 
samples tested exceeded the above-mentioned guidance levels of the US FDA for human 
foods. In another survey, Sydenham et al (45) reported FBi and FB% contamination of corn-
based human foodstuffs from retail outlets in five countries: Egypt, Peru, Canada, South 
Africa and the United States. The highest mean concentrations occurred in one of the 
Egyptian samples, 3.29 pmol FB,/kg and 0.83 jimol FB%/kg. Cornmeal samples from the 
United States contained up to 1.45 jjmol FB,/kg and 0.41 jimol FB^/kg, far below the FDA 
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guidance level of 2.8 pmol FB/kg, for human foods. A recent review by Soriano and 
Dragacci (46) presented data on FB occurrence in crops, cereals, and human foods in 
countries from the five different continents. The highest levels of FBi were found in a corn 
kernel sample from Egypt, 6,227 gmol/kg, while the highest FB% levels were detected in a 
corn sample from Spain, 537 pmol/kg. A moldy corn sample from Korea had the highest 
FB] levels, 15 gmol/kg. All levels found were above the FDA guidance level. 
Several surveys have been conducted in geographical areas of high human risk of 
esophageal cancer such as South Africa and China. A Fusarium mycotoxins survey 
conducted in South Africa by Sydenham et al (34), revealed levels of FBi and FB% in com 
samples from areas of low and high incidence of esophageal cancer in the Transkei region. 
In the low incidence area, mean levels ofFB, and FB% were 9 pmol/kg and 3.6 jamol/kg, 
respectively, whereas in the high incidence area, mean levels of FBi and FBz were 33.1 
jimol/kg and 10.7 ^imol/kg, respectively. Total FB levels in the esophageal cancer-low 
incidence area were still much higher than the FDA guidance level. The concentration of 
total FB in home-grown corn from the Transkei region of South Africa were analyzed in com 
samples collected for six seasons from 1976-1989 (47). Significantly higher levels of both 
FBi and FB% were present in the samples from the high-rate esophageal cancer areas. 
Samples contained FBi and FB% levels up to 163 pmol/kg and 33 jimol/kg, respectively. In 
China, a study performed on the Cixian and Linxian counties of China by Chu and Li (48) 
found FBi levels up to 215 jxmol/kg in household corn food samples that showed heavy mold 
contamination. Samples that did not show any visible mold contamination contained 
concentrations up to 83 pimol/kg. A survey of com samples from the Lixian County in China 
conducted by Yoshizawa et al (49) showed much lower levels of FBi in com samples also 
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collected from households. This study found concentrations up to 4.1 pmol/kg of FBi and 
0.77 pmol/kg ofFBi. These last two surveys seemed to disagree on the FB, levels present in 
com samples of Lixian County, China. However, both showed the presence of FB in com 
foods from areas with high risk of esophageal cancer in humans, frequently in levels higher 
than the FDA guidance level. 
The current occurrence of FB in com grains from the United States is fairly low due 
to control strategies developed to target the production of FB by Fusarium species in the com 
plant. The most effective of those strategies is planting of the commercially available 
Bacillus thuringiensis (Bt) com. Bt com hybrids have been genetically engineered with 
genes derived from the bacterium Bacillus thuringiensis to express CrylAb and other Cry 
proteins that are toxic to certain insects, particularly the European com borer (Ostrinia 
nubilalis). Com kernel feeding by O. nubilalis frequently leads to infection of the com plant 
by Fusarium fungi, including the FB-producing species F. verticillioides and F. proliferatum 
(50). In a recent work, Hammond et al (51) monitored the 2000-2002 occurrence of FB in Bt 
com grown in 107 locations in the United States and compared it to control com hybrids. 
Under conditions of natural insect infestation in the field, FB levels in Bt com were 
consistently at or lower than the FDA guidance level for human foods, 2.7 pmol/kg of com, 
whereas FB levels control com hybrids were usually greater than this level. While currently 
the FB levels in com from the US and other countries might be low due to the use of Bt com, 
the weather conditions that favor FB production by Fusarium in corn may occur 
unexpectedly and consistently increase FB levels. The use of Bt com does not necessarily 
guarantee low FB levels in crops from future years. 
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The vast majority of the surveys of FB occurrence in com foods intended for humans 
reviewed in the preparation of this dissertation found hazardous levels of FB. Although in 
the United States and other developed countries, FB are not such a threat for human and 
animal health currently, it is important to consider that these mycotoxins could unexpectedly 
occur naturally in com at any time under certain weather conditions. Adequate preventive 
and detoxification strategies, like the subject of this dissertation, are important to handle 
possible outbreaks in the event of their occurrence. 
1.3.2.1. Occurrence of fumonisin in animal feeds 
The levels of fumonisins in animal feeds have been reported in only a small number 
of surveys. Osweiler et al (7) reported FBi levels in samples taken from field cases of 
porcine pulmonary edema in Iowa, United States. Levels of FBi up to 349,93 and 61 
Hmol/kg, all greater than the FDA guidance dietary level for swine, 28 pmol/kg, were found 
in samples from com screenings, com and complete prepared rations, respectively (Table 1). 
In a more recent experimental acute FB, toxicosis study in pigs, Fazekas et al (52) reported 
maximal FBi concentrations of 104 (imol/kg in feed rations prepared with com from the 
1995 com crop in Hungary. This level was also higher than the FDA guidance level for 
swine. In a review of worldwide contamination of cereal grains and animal feed with 
Fusarium mycotoxins by Placinta et al (55), total FB levels up to 51.5 p.mol/kg (36, 9.6, and 
5.9 fimol/kg ofFBi, FB2, and FB3 respectively) were reported in a sample from China. This 
review did not specify if the levels reported were from com or animal feed samples but 
showed the occurrence of FB in animal feeds in that asian country. Jindal et al (54) analyzed 
FBi in com and poultry feeds collected in the province of Haryana, India. Contamination 
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with FBi of corn samples intended for animal consumption ranged from 0.1 to 121 gmol/kg, 
whereas poultry feed samples contained levels from 0.03 to 39 |imol/kg. Both upper 
extremes were higher than the FDA guidance level for swine. 
1.3.3. Fumonisln-synthesizing fungal species 
At the end of the 19th century, farm animal disease outbreaks in the United States 
were associated with "moldy corn poisoning" caused by consumption of corn ears, stalks, 
and fermented silage heavily-contaminated with a fungus described as Fusarium moniliforme, 
one of the main fungal producers of FB. The fungi then described as F. moniliforme are 
currently considered to comprise at least six different species, three of which are F. 
verticillioides, F. proliferatum and F. subglutinans (55). To clarify the taxonomy of this 
complex genus, Giberella fujikori was organized into eight mating populations (A-H). 
Fungal species that belong to the same mating population can cross to produce viable 
offspring. Fusarium moniliforme, renamed F. verticillioides in 1976 by Nirenberg, belongs 
to the mating population A and is a prolific fumonisin producer. In fact, this species is 
considered the predominant fumonisin-producing fungi in corn grown in the United States 
and many other regions of the world (56). Fusarium verticillioides occurs worldwide on a 
variety of plan hosts other than corn such as millet and sorghum, and is one of the most 
prevalent fungi associated with dietary staples such as corn (45). A member of the mating 
population D, F. proliferatum, is also described as a significant producer of the mycotoxin. 
The species F. subglutinans (mating population H), however, is considered a poor fumonisin 
producer. Other less common Fusarium species have also been found to produce fumonisins. 
Fotso et al (57) studied the production of fumonisins by fifteen different species of Fusarium. 
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The study found that species such as F. acutatum, F. begoniae, F. brevicatenulatum, F. 
phyllophilum and F. pseudocircinatum, were capable of producing FBi, FB% or both. 
The weather conditions associated with the occurrence of Fusarium ear rot in corn 
and the production of fumonisins by Fusarium are not well understood. A 2003 mycotoxins 
report of the Council for Agricultural Science and Technology (CAST) at Iowa, United 
States (58), claims that the three main fumonisin-producing Fusarium species: F. 
verticillioides, F. proliferatum and F. subglutinans, differ in optimum temperatures and 
moisture conditions for infection of the com plant. This report also states that F. 
subglutinans is more prevalent in cooler areas than F. verticillioides. Several studies have 
associated severe ear rot with dry weather conditions during June and July early in the corn-
growing season, especially when followed by wet weather during the silking phase and later 
in the growing season (58, 59). Silks are more susceptible to infection during the first week 
of silking whereas moisture on the silks favors infection (60, 61). In general, it is believed 
that a period of drought during the growing season, followed by cool, wet conditions during 
pollination and development of com favors FB production. 
1.3.3.1. Role of fumonisins in Fusarium infection of corn plants 
Interestingly, fumonisins do not appear to have a role in the infection of com plants 
by F. verticillioides. In a study by Desjardins et al (62), fumonisin-nonproducing mutants of 
this fungal species were obtained by disrupting FUM1, the gene that encodes a polyketide 
synthase required for fumonisin biosynthesis. Results showed that two independent 
fumonisin-nonproducing mutants (fum 1-3 and fum 1-4) were similar to their fumonisin-
producing progenitor strains (FUM1-1) in ability to cause ear rot following silk-channel 
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infection, which confirmed that fumonisin was not needed by the fungus to cause infection. 
The role of FB in the fungal viability or infectivity of F. verticillioides is not clear. 
1.3.4. Chemistry of fumonisins 
Fumonisins are a group of at least 15 related compounds, the most prevalent one 
being fumonisin B,. Chemically, this mycotoxin is known as 1,2,3-propanetricarboxylic acid, 
1,1 [1 -( 12-amino-4,9,11 -trihydroxy-2-methyl-tridecyl)-2-( 1 -methylpentyl)-1,2-ethane-diyl] 
ester (27) (Figure 1). It is also described as 2S-amino-12S', 16i?-dimethyl-3S, 5R, 10R, 14S, 
15/?-penta-hydroxy-eicosane with the C-14 and C-15 hydroxyl groups esterified by a 
terminal carboxyl group of propane-1,2,3-tricarboxylic or tricarballylic acid (TCA). The 
chemical formula of FB, is C34H59O15 and is also known as macrofusine (63). Fumonisin B% 
is a 10-deoxy FB,, FB3 is a 5-deoxy FB, while FB4 is similar to FB3 but with no hydroxyl 
group inC-10. Fumonisins A, and A? contain acetyl amino groups instead of amine groups 
in the second carbon position (C-2). Fumonisins C,, C2, C3 and C4 lack the C-l terminal 
methyl group characteristic of FA and FB (4). Because of the four free carboxyl groups and 
the amine group in FB, these compounds are water soluble, but not soluble in nonpolar 
organic solvents. This might explain in part why it was so difficult to make their discovery, 
as isolation of most mycotoxins depends upon solvent extraction. The primary amine group 
(NH2) located in C-2 of all known fumonisin molecules is probably able to react with 
reducing sugars such as lactose, fructose or glucose, through the non-enzymatic browning 
reaction (NEB). The toxicity of the products of this reaction, particularly of the FB-glucose 
products, was tested in swine models described in the two research papers presented in this 
dissertation. 
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Figure 1. Structures of fumonisins (A) and hydro lyzed fumonisins (B). 
1.3.4.1. Hydrolyzed fumonisin B; 
A hydrolyzed form of FB,, hydrolyzed fumonisin Bi (HFB,), also called aminopentol 
(APj), is a by-product of the chemical treatment of FB 1 -contaminated corn based foods in 
some regions of the world. In the preparation of tortillas, a popular com food in some 
regions of Central America (i.e. Guatemala) and Mexico, com is treated with a calcium 
hydroxide (lime) solution and heat (64). This process hydrolyzes the tricarballylic acid side-
chains from FBi, leaving the aminopentol backbone (AP,), also denominated HFB, (Figure 
1). Since the primary amine group of the HFBi molecule is left intact by this chemical 
process, reducing sugars might also be able to react with it and detoxify HFB;. 
1.3.5. Toxicokinetics and metabolism of fumonisins 
In order to understand the toxic potency of FBi, it is necessary to address how it 
enters, distributes and is excreted in sensitive animal species. The availability of large 
amounts of pure FBi is commonly a limiting factor in research studies involving its use. This 
might be one of the reasons why the majority of the studies on the toxicokinetics ofFBi have 
been performed in rodents such as mice and rats, as the amounts ofFBi needed are generally 
small. The excretion ofFBi, HFB, and the FBi-fructose adduct in rats was examinated by 
Hopmans et al (65). This study was one of the first attempts to determine the effectiveness of 
FBi-reducing sugar adducts in detoxifying FBi in vivo. The animals were dosed by gavage 
with 0.69, 6.93 or 69.3 (xmol/kg BW of the three compounds. The average total FB, 
backbone excretion in feces was 101, 76 and 50% of the dose of FBi, HFBi, and FBj-
fructose, respectively, showing that FBi was probably not metabolized in rats and was fully 
excreted in feces. The average total FB, backbone excretion in urine was 2.7, 5.0, and 5.3% 
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of the FB], HFB], and FBi-fructose of the doses, respectively, which agreed with the fecal 
excretion fractions. The FBI-fructose appeared to be absorbed to the highest extent, followed 
by HFBI and FBI. This study also concluded that the greater absorption of HFBI compared 
to FBI could explain the greater toxicity of HFBI when compared to FBI on a molar basis. 
The significance of these findings will be mentioned again in a later section in which the 
importance of the absorption of FBI-reducing sugar adducts in discussed. In a later study by 
Dantzer et al (66), the excretion of I4C-FBI, 14C-HFBI, and 14C-FBI-fructose in rats was 
investigated. Male and female F344/N rats were dosed by gavage with 0.69 fimol/kg BW of 
the three compounds. The urinary excretion of L4C-FBI and I4C-FBI-fructose was 0.5% and 
4.4%, respectively. This showed that the oral bioavailability of 14C-FBI-fructose was about 
8.8 times higher than that of 14C-FBI. The urinary excretion of 14C-HFBI was reported to be 
about 25 times higher than 14C-FBI, suggesting a much greater absorption of L4C-HFBI as 
compared to 14C-FBI. Based on these findings, the study concluded that once in circulation, 
HFBI was less toxic than FBI on a molar basis, which contrasted with the findings of 
Hopmans et al (65). This study did not show a significant difference in biliary excretion of 
the three compounds 4 h after dosing. In addition, the lower absorption of FB, as compared 
to HFBi and FBi-fructose was confirmed. Martinez-Larranaga et al (67) also studied the 
toxicokinetics and oral bioavailability of FBi in rats. A single dosage of 14 pmol FBi/kg 
BW orally or 3 pmol FBi/kg BW IV were administered to male Wistar rats. The FBi plasma 
profile was described as a 2-compartment open model; elimination half-life from plasma was 
1.03 h after IV and 3.15 h after oral administration. After the oral dosage, FBi was rapidly 
absorbed with a time of maximum plasma concentration of 1.02 h. Maximum plasma 
concentration was 200 pmol FBi/mL. Bioavailability was calculated as 3.5%, a much higher 
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value than reported by Dantzer et al (66), who used a much lower oral FBj dosage. The 
difference in the dosages, however, would not account for this difference as bioavailability is 
expressed as a percentage of the initial dosage and not as an absolute value. Residue 
accumulation was higher in kidneys than in liver, which agreed with previous studies in 
swine that will be discussed later in this review. Metabolism of FBi has also been studied in 
rodents. Cawood et al (68) demonstrated in a rat study that there is no metabolism of FB, in 
rats by two microsomal enzyme systems, the esterases and cytochrome P450-dependent 
monooxygenase. 
Shephard and Snijman investigated the toxicokinetics of a different type of FB, FBz, 
in vervet monkeys (69). The animals were dosed IV with 3 pmol FB^/kg BW or by gavage 
with a single bolus at 10 pmol FB^/kg BW. Monkeys dosed IV showed a plasma FB% 
concentration characterized by an initial distributional phase and a subsequent elimination 
phase with a mean half life of 18 min. Animals that were orally dosed showed only 
detectable trace levels of FB% in plasma (0.03-0.06 fimol/mL 3-5 h after dosing), which 
indicated that FB%, like FBi, has a limited oral bioavailability. The urinary excretion of FB2 
was very low (4.1% and 0.2% after IV and oral dosing, respectively) over a 7-d period. The 
main route of excretion was feces, mainly as the intact unmetabolized form or as a partially 
hydrolyzed analogue accounting for 6-47% of the dose. According to the authors, the 
hydrolysis must have occurred in the gut by the action of intestinal esterase enzymes or the 
action of microorganisms that remove only one of the tricarballylic acid groups in the FB 
molecule. 
The biotransformation ofFB, has been investigated in species that are little sensitive 
to the mycotoxin, perhaps trying to obtain more information on the species-specificity of it. 
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The tolerance of ruminants to fumonisin has been investigated from a metabolic point of 
view. Rice and Ross found elevated concentrations of the hydrolyzed metabolites of FBi, 
aminopolyols and aminopentols, in feces of ruminants (70). In contrast, a study by Caloni et 
al (71) looked at the in vitro metabolism ofFBi by the ruminai microflora by incubating 
0.001 nmol FBi/mL of ruminai fluid for 72 h with or without the presence of alfalfa as a 
substrate for microbial growth. Depletion of FB, was 12% and 18% in samples with or 
without growth substrate. No aminopolyols or aminopentols, hydrolyzed metabolites of FB,, 
were detected, suggesting that FB, was poorly metabolized in rumen. Subsequently, ruminai 
metabolism of FB, was ruled out as the cause of the ruminants' tolerance to the mycotoxin. 
Moreover, Spotti et al (72) studied the FB, metabolism by bovine liver microsomal fractions. 
Contents of P450 enzymes were determined spectrophotometrically. The metabolism of the 
mycotoxin was measured in a standard assay mixture that included 28, 14 or 7 (J.M FB, and a 
nicotinamide adenine dinucleotide phosphate (NADPH)-regenerating system. No 
aminopolyol 1 or aminopolyol 2 (partially hydrolyzed FB, without one or the two 
tricarballylic acid-side chains) or aminopentol were detected in any of the incubated samples. 
This study reached the same conclusion as Caloni et al (71): that the tolerance of ruminants 
to FB, is apparently not dependent on its ruminai detoxification. 
1.3.5.1. Toxicokinetics of fumonisin in swine 
More significant for the subject of this dissertation is the study of FB, toxicokinetics 
in pigs. The kinetics of 14C-FBi in swine were initially described by Prelusky et al (43). 
Animals were administered IV 0.55 pmol I4C-FB|/kg BW, or intragastrically 0.7 gmol l4C­
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over 72 h, and assayed for specific activity. After IV injection, plasma concentration-time 
profiles were triexponential. The half lives in the different distribution phases were a, 2 min 
(distribution); p, 10 min (elimination); and y, 182 min (slow terminal elimination). The 
labelled mycotoxin had a volume of distribution of 2.4 L/kg BW, meaning that it was widely 
distributed. The plasma clearance was of 9.1 mL/min/kg, a moderate rate. Three to 6%, a 
much higher proportion than in rodents, was absorbed, while excretion at 72 h after 
administration was mainly in feces (60%), followed by urine (20%). In bile-interrupted pigs 
the absence of the y phase suggested that FBi underwent enterohepatic circulation. Biliary 
recovery was 70.8% of the IV dose. Only trace levels of radioactivity remained in plasma 
after 3 d, being 10 to 20-fold lower than the IV dose. Residues of fumonisin in tissues were 
greatest in liver, followed by kidney, large intestine, brain, lung, heart and adrenal gland. 
According to this study, it was apparent that FB% was more bioavailable in pigs than in 
rodents. 
A later study by Prelusky et al (73) looked at the fumonisin residues accumulated in 
liver and kidney after feeding pigs 4 (imol 14C-FBI/kg feed from d 1-12, followed by 3 pmol 
14C-FBI/kg feed during d 13-24, followed by a 9-d withdrawal period where pigs received 
clean feed only. Residues were found to accumulate only in liver and kidney. Radioactivity 
was detected at the first sampling time (d 3), and continued to increase until 14C-FBI was 
removed from the diet. Peak levels in liver and kidney were equivalent to about 0.22 and 
0.09 |j.mol FB, and/or metabolites/g tissue, respectively, on d 24. After pigs were given 
clean feed, tissue levels declined rapidly to approximately 35% of peak levels after 3 d, and 
only marginally above detection limits after 9 d. A delayed recovery of the radioactive 
material indicated a persistence of FB,-derived residues, which could be eliminated only 
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upon removal of the contaminated diet. This study pointed out that pigs exposed to a dietary 
level of 3-4 pmol FBi/kg would require a withdrawal period of at least 2 wk to ensure that 
only minimal residues are present in edible tissues. A more recent study by Meyer et al, 
analyzed the formation ofFBi residues in porcine tissues (74). Pigs were orally administered 
139 fimol FBi/animal/d for a 5-11 d period. Results confirmed the findings of Prelusky et al 
(73). The highest levels ofFBi were found in kidney (1.15 nmol/g tissue), liver (0.32 
jimol/g) and lungs (0.24 jimol/g). Muscle and fat contained 0.04 and 0.003 |imol FBi/g 
tissue but this carry-over ofFBj to edible tissues was not considered of toxico logical 
relevance. This conclusion was less conservative than in Prelusky et al (73), who suggested 
a 2-wk withdrawal period. Considering the extremely low concentration of FB residues 
found in edible tissues in these two studies, and the low oral bioavailability of FB reported 
for rats and swine in studies previously mentioned, the risk associated with ingesting FB in 
swine-derived foods in humans may be considered negligible. Therefore, the 2-wk 
withdrawal period reported by Prelusky et al (73) may not be accurate. 
In general, FB; is absorbed poorly from the gastrointestinal tract, is cleared rapidly 
from circulation in the plasma, and is excreted primarily in feces even after IV administration 
in all species. Small quantities are retained mainly in liver and kidneys and are excreted in 
urine. There is little evidence of metabolism with no retention of the mycotoxin in edible 
tissues, which is a significant implication to sources in human food. Interestingly, FBi is a 
powerful toxin for some species such as horses and pigs, even when its absorption and 
bioavailability are very low and there is no production of reactive metabolites. The toxic 
effects of FB will be discussed in the following section. 
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1.3.6. Toxicity of fumonisin 
One of the interesting characteristics of FB is its capacity to exert toxicity upon 
different cells lines in various organs and systems within the organism. The versatile toxicity 
of FBi has been investigated in numerous studies including several animal models such as 
equine, swine, primates, rodents, rabbits and fish. Numerous cell lines have also been 
exposed to FBi during in vitro studies to elucidate the different aspects of the mechanism of 
action of this mycotoxin. The following sections will provide a brief insight to what is 
currently known about the toxicity of FB,, starting with the sphingo lipid synthesis disruption, 
the apparent starting point in the pathogenesis of FB-induced diseases in animals and humans. 
1.3.6.1. Sphingolipid alterations 
The information presented in this section refers to the cellular as well as molecular 
changes produced by alteration of sphingolipid metabolism by fumonisins. Broader effects 
such as the onset of PPE or liver damage in pigs and ELEM in horses by sphingolipid 
metabolism disruption will be presented in following sections of this dissertation. 
1.3.6.1.1. What are sphingolipids? 
Sphingo lipids are a class of lipids that serve in eukaryotic cells as important 
structural molecules in cell membranes and as regulators of many cell functions (75). 
Sphingosine, one of the sphingoid base precursors of major sphingolipids, is an 18-carbon 
amino alcohol that forms the backbone of sphingolipids and that only differs from 
sphinganine, another precursor sphingoid base, in a double bond between C-4 and C-5 
(Figure 2). In animal cells, the initial steps from the condensation of serine and palmitoyl-
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CoA through the formation of ceramide, one of the major sphingolipids, take place in the 
endoplasmic reticulum (Figure 3). Subsequent biosynthesis of glycosphingolipids and 
sphingomyelin, another major sphingolipid important in the nervous tissue of higher animals, 
takes place in the Golgi apparatus. The degradation of complex sphingolipids occurs in the 
lysosomes, endosomes, and the plasma membrane. Degradation of free sphingoid bases 
occurs in the cytosol. 
1.3.6.1.2. Synthesis of sphingolipids 
For the purposes of this dissertation, the complex biosynthesis of 
sphingolipids in cells will be briefly explained (Figure 3). The first step is the condensation 
of serine with palmitoyl-CoA by serine palmitoyltransferase. The resulting 3-
ketosphinganine is reduced to sphinganine (Figure 2) using NADPH. Sphinganine is then 
acylated to dihydroceramides (N-acyl-sphinganines) by ceramide synthase, using various 
fatty acyl-CoAs. Subsequently, headgroups are added to the 1-hydroxyl group. A 4,5-trans-
double bond is added to the sphingosine backbone after acylation of the amino group. 
Sphingolipid turnover involves the hydrolysis of complex sphingolipids to ceramide and then 
to sphingosine and sphingosine 1-phosphate. Sphingosine is either reacylated or 
phosphorylated and cleaved to a fatty aldehyde and ethanolamine phosphate, which is 
incorporated into phosphatidylethanolaminde (14). 
Functions of sphingolipid molecules include regulation of cell growth, 
differentiation, and neoplastic transformation through participation in cell-cell 
communication and cell-substratum interactions and possible interactions with cell receptors 
and signaling systems. Wang et al first reported the inhibition of sphingolipid biosynthesis 
CH2OH 
Figure 2. Structures of sphingosine (A) and sphinganine (B). 
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Figure 3. De novo biosynthetic pathway for sphingoid bases and complex sphingolipids. 
Inhibition of the enzyme ceramide synthase by FB is shown. 
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by fumonisins in a breakthrough study (13). The basis for this important discovery was the 
remarkable similarity between the chemical structures of fumonisins and sphingosine, the 
long-chain sphingoid base backbone of sphingomyelin, cerebrosides, sulfatides, gangliosides, 
and other sphingolipids (Figures 1 and 2). 
1.3.6.1.3. Disruption of sphingolipid metabolism by fumonisin 
Fumonisins (Bi, B2, B3, and hydrolyzed FBi) and Alternaria toxin inhibit the 
acylation of sphingosine and sphinganine by inhibiting the enzyme sphingosine N-
acyltransferase (ceramide synthase) in the de novo sphingolipid synthesis pathway. As a 
result of this inhibition, large increases in free sphinganine, and sometimes in sphingosine 
concentrations in animal cells are observed within a few h after FB exposure (14). Wang et 
al (13) demonstrated that rat hepatocytes incubated with FB, showed an inhibition of the 
incorporation of 14C-serine into the sphingosine moiety of cellular sphingolipids. In addition, 
FBi increased the amount of the sphingolipid synthesis pathway intermediate sphinganine, 
which indicated that fumonisins inhibit the conversion of I4C-sphinganine to N-acyl-,4C-
sphinganine, a step that precedes the introduction of the 4,5-trans double bond of sphingosine. 
The study also reported that FBi inhibited the activity of the enzyme ceramide synthase in 
rat liver microsomes and reduced the conversion of 3H-sphingosine to 3H-ceramide by intact 
hepatocytes. Fumonisin was also shown to inhibit ceramide synthase in renal epithelial LLC-
PKi cells (76). One of the first animal studies in which the increase of sphingoid bases was 
measured after exposure to dietary fumonisins was done in ponies (77). Six horses were fed 
FB]-contaminated diets at levels of 21-61 |i mo l/kg of diet for a 13-d period. At d 10 of the 
study, there was an increase in the amount of sphinganine and sometimes sphingosine and a 
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reduction of complex sphingolipids. Interestingly, free sphinganine and sphingosine 
decreased when ponies consumed less feed and increased again when they consumed more 
FB-contaminated feed, which suggested a dose-response relationship between FB exposure 
and sphingoid base levels in horses. Liver enzyme increases were also seen but after the 
elevation in sphingoid bases, indicating that changes in sphingolipid levels might be used as 
early biomarkers of FB exposure in the form of the Sa/So ratio. Fumonisin Bi has also been 
found to disrupt the sphingolipid metabolism in fish (78). Nile tilapias (Oreochromis 
niloticus) were fed diets containing FB% in levels from 0-208 (imol/kg for an 8-wk period. 
The Sa/So ratio was increased in fish fed the highest FBi level, suggesting that fish are also 
probably susceptible to the toxic effects of the mycotoxin. Alterations in sphingolipid 
metabolism have been related to adverse effects in kidney. Riley et al (79) proposed a new 
mechanism of nephrotoxicity in a study where the sphingolipid metabolism was disrupted 
after feeding Sprague-Dawley rats dietary FBi at levels of 21 to 208 pmol/kg diet. The 
accumulation of free sphinganine and the increase in the Sa/So ratio in urine closely reflected 
the changes in sphingolipids that occurred in kidney, suggesting that urine rather than serum 
was the biological fluid of choice for diagnosing FB-induced kidney damage. In an in vitro 
study in kidney, the elevation in sphingoid bases and depletion of complex sphingolipids 
were found to be contributing factors in FB-induced cytotoxicity of pig kidney LLC-PK, 
cells (80). A general perspective of the toxic effects of sphingoid bases accumulation was 
given by Riley et al in a review of the role of the disruption of sphingolipid metabolism as a 
contributing factor in the toxicity of fumonisins (14). The review stated that free sphingoid 
bases are toxic to most cells, while complex sphingolipids are essential to normal cell growth. 
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The disruption of the sphingolipid metabolism by FB in swine will be thoroughly discussed 
in the two research papers presented in this dissertation. 
13.6.13.1. Consequences of sphingolipid metabolism disruption 
The inhibition of the enzyme ceramide synthase by FB is likely to 
affect sphingolipid-mediated regulation of important cell events such as apoptosis and 
mitosis, which are probably in part responsible for the cytotoxic and carcinogenic properties 
of the mycotoxin (81, 82). The mechanism for induction of apoptosis probably involves 
inhibition of the protein kinase C (PKC) cell regulatory pathway, a key hallmark of apoptotic 
signaling, by accumulation of sphingoid bases in the cell (83, 84). Additional in vitro studies 
have suggested that FBi-induced apoptosis involves the activation of caspase 3, the enzyme 
responsible for final execution in the cellular apoptosis pathway. This activation has also 
been associated with repression of PKC and possibly its down-stream effectors, nuclear 
factor-kappa B (NF-KB) and tumor necrosis factor a (TNFa) (85). Alterations in mitosis or 
cell growth have been shown to be due to up-regulation of inhibitors of cyclin-dependent 
protein kinases (Cipl, Kipl and Kip2) at both transcriptional and post-transcriptional levels. 
As suggested by several studies, other molecules that appear to be 
modulated by FB;-induced sphingolipid changes, such as the previously mentioned cytokine 
TNFa, are involved in the mechanism of action of FBi as well. Macrophages from FBi-
treated mice produced higher amounts of TNFa than macrophages from untreated mice after 
stimulation with lipopolysaccharide. The hepatotoxic response to FB; in mice can be altered 
in animals lacking TNFa receptors (82, 86). Gopee et al reported that short-term exposure of 
LLC-PKi cells to FB, sequentially activated NF-KB leading to TNFa induction via a 
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selective and transient PKC-dependent pathway (87). Although it is not clear if FB, is 
genotoxic, its DNA-damaging activity has been documented. Experiments performed on cell 
cultures have shown that FB, stimulates sphinganine-dependent DNA synthesis in Swiss 3T3 
cells but is mitoinhibitory in other cell types. The accumulation of bioactive long-chain 
sphingoid bases and depletion of complex sphingolipids are believed to be contributing 
factors in growth inhibition, increased cell death and mitogenicity of fumonisins in some 
cells such as Swiss 3T3 cells (14). Human fibroblasts and rat astrocytes exposed to FB, 
showed DNA damage, and enhancement and cleavage of the enzymes caspase-3 and poly 
(ADP-ribose) polymerase (PARP), respectively. These two enzymes are known to be 
involved in apoptosis (88). The study speculated a possible involvement of accumulated 
sphingoid bases in triggering of apoptosis by stimulation of caspases. 
Riley et al discussed the sphingolipid perturbations as mechanisms for 
fumonisin-induced carcinogenesis in an excellent review (81). The article stated that the 
biochemical consequences of FB-induced disruption of sphingolipid metabolism, most likely 
to alter cell regulation, were the increased free sphingoid bases and their 1-phosphates, 
alterations in complex sphingolipids, and decreased biosynthesis of ceramide. Since the cell 
normally interprets free sphingoid bases and ceramide as death signals, the FB-induced 
inhibition of ceramide synthase could inhibit cell death induced by ceramide but stimulate 
free sphingoid base-induced cell death due to increases in sphingoid bases. To understand 
why fumonisins are able to induce carcinogenesis, it is important to be aware of several 
cellular events. According to Riley et al, the balance between the intracellular concentration 
of molecules that protect cells from apoptosis (i.e. decreased ceramide, increased sphingosine 
1-phosphate) and those that induce apoptosis (increased ceramide, free sphingosine or 
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sphinganine bases, altered fatty acids) would determine the response of the cell to a certain 
stimulus. Given that the balance between the rates of apoptosis and proliferation is important 
in tumorigenesis/carcinogenesis, the cells that are sensitive to the proliferative effect of low 
levels of ceramide and increased levels of sphingosine 1-phosphate might be selected to 
survive and proliferate when the concentrations of free sphingosine or sphinganine do not 
inhibit cell growth. In contrast, when the ability of cells to convert sphinganine/sphingosine 
to dihydroceramide, ceramide or an sphingoid base 1-phosphate is exceeded by the increase 
in free sphingosine or sphinganine, these sphingoid bases would accumulate. The cells that 
are sensitive to sphingoid base-induced growth arrest would die and insensitive cells would 
survive and grow. If the cells prone to die are normal genetic phenotypes and the cells 
selected to live are abnormal, carcinogenesis may occur. 
Alterations in sphingolipid metabolism are a constant in all diseases 
caused by FBi in sensitive species. A discussion of the FB-induced animal diseases will be 
presented as follows. 
1.3.6.2. Neurotoxicity 
It is well documented in the literature that horses are the most sensitive species to FB|. 
However, evidence of neurological damage by FBi has also been found in other zoologically 
unrelated species such as rabbits (89). This section begins with a brief review of what is 
known about equine leukoencephalomalacia caused by FBj exposure. Equine 
leukoencephalomalacia is a neurotoxic disease of horses, donkeys and mules, characterized 
by multifocal liquefactive necrosis of predominantly the white matter of the cerebral 
hemispheres (5, 6). Field outbreaks of the disease have occurred sporadically in many 
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countries, including the United States (21). Although FBi had not been discovered yet, 
Butler reported brain lesions characteristic of ELEM in equines as early as 1902 after feeding 
naturally contaminated moldy com to horses (20). In one of the late 1980s many important 
studies on FB%, Marasas et al dosed by stomach tube two horses with 1.25 and 2.5 g of F. 
moniliforme com culture material/kg BW/d for 6 d (28). The FBi concentration of the 
culture material was not specified in this study but the authors claimed that the F. 
moniliforme strain used, MRC 826, had previously been shown to cause ELEM and hepatosis 
in two horses (25). One more horse was IV dosed seven times with 0.17 gmol pure FBi/kg 
BW for a 9-d period. The orally dosed horses developed mild to severe hepatosis and mild to 
moderate brain edema that were mainly evident in the medulla oblongata. The horses dosed 
IV developed obvious clinical signs of neurotoxicosis at d 8 such as nervousness followed by 
apathy, a wide-base stance, trembling, ataxia, reluctance to move, paresis of the lower lip and 
tongue, and inability to eat or drink. Observed gross lesions consisted of severe cerebral 
edema and early, bilateral symmetrical, focal necrosis in the medulla oblongata. This work 
clearly showed that horses are very susceptible to FBi. Kellerman et al (29) also dosed two 
horses via stomach tube with 1.7-5.5 nmol of 50% pure FBi/kg BW for a 33-d period (total 
82 pmol FBi/kg BW), and 1.4-5.5 |xmol of 95% pure FBi/kg BW for a 29-d period (total 61 
(j. mol FBi/kg BW), respectively. Both animals developed characteristic signs of ELEM 
similar to those observed in previous work by Kellerman et al (5) and Marasas et al (28). 
The role of other fumonisins, FBz and FB;, in neurotoxicity of horses, was evaluated 
in a study where the disruption of sphingolipid metabolism and induction of ELEM by F. 
proliferatum culture material containing FB% or FB3 were studied by Riley et al (90). Horses 
consuming contaminated diets at 104 pmol FB% or FBs/kg, showed a significant increase of 
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the Sa/So ratio at d 4 and 11 of the study, respectively. Although both mycotoxins were 
effective at inducing changes in sphingolipid metabolism in the horses, the FB; culture 
material was more efficient at producing clinical signs indicative of the onset of ELEM. 
Thus, FBz was believed to be a more potent inhibitor of ceramide synthase than FB3 in this 
study. More recently, Foreman et al studied the neurologic abnormalities and cerebrospinal 
fluid (CSF) changes in 17 horses administered IV FBi dosages from 0-0.27 gmol FBi/kg BW 
every 24 h for a 28-d period (91). The objective of the study was to determine whether there 
was a dose-dependent effect of chronic daily FBi administration in equine. Signs of ELEM 
and CSF changes, consistent with vasogenic cerebral edema, were observed in a dose-
dependent manner in horses administered FBi dosages equal or greater to 0.07 pmol FBi/kg 
BW. Changes in CSF consisted of higher than normal CSF protein, albumin, and IgG 
concentrations. The no-observable-effect level (NOEL) was determined at 0.013 p.mol 
FBi/kg BW, which seemed too low based on the US FDA FB, guidance level for feed 
intended for horses (7 p.mol FBi/kg feed). 
1.3.6.2.1. Neurotoxicity in rabbits 
Leukoencephalomalacia from FB] exposure has also been observed in rabbits. 
In a simple but significant work, Bucci et al gavaged five pregnant rabbits with purified FB, 
at 2.4 ^mol/kg BW/d for up to 13 d (89). Two of the dams, after 9 and 13 dosages, 
respectively, died from the treatment, showing bilateral focal hemorrhages in white matter 
and hippocampus regions of the brain, lesions consistent with leukoecephalomalacia. In 
addition, marked degeneration of the renal tubule epithelium and of hepatocytes were 
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observed, also consistent with FB,-induced changes. These findings indicated the potential 
use of rabbits as an FBi-induced ELEM and kidney damage animal model. 
1.3.6.2.2. Neurotoxicity in vitro 
At the cellular level, in vitro studies have shown neurological damage by FB,. 
Monnet-Tschudi et al showed loss of the astrocyte cytoskeletal marker glial fibrillary acidic 
protein (GFAP) due to a deficit of sphingolipids from blockage of the enzyme ceramide 
synthase in the de novo sphingolipids synthesis pathway (92). In this study, FB, could have 
acted as protective agent by inhibiting ceramide synthase, given that in certain stress 
conditions such as in hypoxic injured LLC-PK1 cells, an increase in ceramide synthase 
induces DNA fragmentation and apoptosis (93). In order to determine the interaction 
between FB, exposure and DNA damage in astrocytes, Galvano et al exposed astrocyte cell 
cultures from rat brain to FB, concentrations of 50 and 100 p.M for 72 h (94). Results 
indicated DNA damage evidenced by DNA fragmentation as well as an enhancement of 
caspase-3 activity, which indicated its possible apoptotic nature. More recently, FB, was 
found to induce toxicity and oxidative damage in glioblastoma cells. Stockmann-Juvala et al 
exposed human U-118MG glioblastoma cells to 0.01-100 (iM for 0.5 - 144 h (95). The 
mycotoxin induced lipid peroxidation, evidenced by an increase in the concentration of 
malondialdehyde, and production of reactive oxygen species (ROS) in these cells. In 
addition, decreases in intracellular glutathione levels and cell viability as well as increases in 
caspase-3-like protease and internucleosomal DNA fragmentation were observed. Altogether 
these results indicated that oxidative stress and apoptosis might be involved in FB,-induced 
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neurotoxicity. These studies did not suggest ELEM as a likely consequence of the 
occurrence of oxidative stress or apoptosis after FB exposure. 
13.63. Porcine pulmonary edema 
Fumonisin Bi induces hemodynamic changes in the cardiovascular system of swine. 
Although a separate section of this review is dedicated only to FBi-induced cardiotoxicity in 
horses and swine, there are cardiological events that need to be discussed in order to 
understand the pathogenesis of FBi-induced PPE. Several studies have indicated that FB, is 
a negative inotropic (influencing the force of muscular contractions) agent that decreases the 
cardiovascular reserve of pigs (96-98). The decreased cardiac contractility appears to be 
responsible for increasing the pulmonary artery wedge pressure, which is an index of 
pulmonary capillary pressure; and for the subsequent pulmonary edema as a result of failure 
of the left side of the heart to contract. Haschek et al (18) proposed that the FB,-induced 
increase in heart and/or serum sphingosine levels inhibits the L-type Ca2+ channels of cardiac 
myocytes, decreasing Ca2+-induced Ca2+ release necessary for muscle contraction, and 
ultimately decreasing cardiac contractility. This remains to be confirmed in further studies. 
Several swine studies have confirmed that FBi can produce pulmonary edema in 
swine. Harrison et al observed pulmonary edema in two pigs fed FB i -contaminated corn 
screenings at levels of 145 jimol/kg of feed for a 5-d period (30). The study also reported 
PPE in one pig that received daily IV dosages of 0.55 {xmol FBi/kg BW for a similar 
exposure time. Pigs that were exposed to FBi but did not show clinical signs of PPE 
developed hepatic disease. This trend seems to be consistent in pigs and horses that do not 
develop PPE after being exposed to high FBi levels and will be discussed in this review's 
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hepatotoxicity section later. Although the number of experimental subjects in the study by 
Harrison et al (30) was small, the results were consistent enough to show the high 
susceptibility of pigs to FB,. Interestingly, pancreatic lesions were reported in all pigs that 
developed PPE. These lesions consisted of focal to massive pancreatic necrosis, acinar cell 
dissociation, and rounded individual acinar cells. Haschek et al observed mild interstitial 
pulmonary edema in one pig administered 1.2 pmol/kg B W/d IV within 5 d, whereas severe 
interstitial pulmonary edema was diagnosed in two pigs fed 230 pmol FB/kg feed for a 6-d 
period (99). This study also reported pancreatic necrosis in pigs that suffered from PPE and 
liver disease. Osweiler et al studied an epizootic of PPE in Iowa (7). In that study, 
contaminated corn screenings at 127 gmol FB,/kg of corn material that were obtained from 
an Iowa farm where a typical outbreak of PPE and abortions had occurred, were 
experimentally fed to weanling pigs for up to 21 d. Some animals started to show signs of 
acute PPE as early as on d 4 and died on the same day. Pigs that survived PPE as well as 
pigs that were administered 0.011 pmol FB,/kg BW for a 14-d period developed clinical 
signs and lesions characteristic of subacute hepatotoxicosis. Two recent studies by 
Zomborszky-Kovacs et al tried to establish tolerable limits of dietary FB, chronic exposure 
in pigs. In the first of those studies, PPE was produced in pigs fed FB,-contaminated feed at 
a level of only 14 pmol FB,/kg feed for a 4-wk period (100). Moreover, in the second study, 
chronic pulmonary changes consisting of irreversible fibrosis were observed in levels as low 
as 1.4 pimol FBi/kg feed for 2-20 wks (101). Based on the results of other studies discussed 
in this dissertation, it is difficult to acknowledge that pulmonary lesions could be observed in 
cases of chronic exposure to levels as low as 1.4 or 14 jimol FB,/kg BW. It is necessary to 
recall at this point that the US FDA guidance FB dietary level for pigs is 28 gmol total FB/kg 
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BW, 19- and 2-fold as much as in the first and second studies by Zomborsky-Kovacs, 
respectively. More data would be needed to confirm these findings. 
Gross examination of pigs that die in respiratory distress from PPE usually reveals 
heavy, wet lungs with widened interlobular septa as well as fluid in the airways and the 
thoracic cavity (hydrothorax) (18). Osweiler et al reported accumulation (200-350 mL/pig) 
of clear straw-colored thoracic transudate in the thoracic cavity of affected pigs (7). Lungs of 
PPE-affected pigs are generally heavy and fail to collapse when removed from the thorax. 
The pattern of edema is predominantly interstitial and interlobular, being interlobular edema 
more prominent throughout the lung. Microscopic lesions include the presence of clear fluid 
and markedly dilated lymphatics in the connective tissue around blood vessels and bronchi as 
well as in the subpleura and in the interlobular septa. In more severe cases of PPE, the 
edema fluid may contain proteins that could be found in alveoli and airways (18). In a more 
ultrastructural approach, accumulation of membranous material (multilamellar bodies) has 
been observed within pulmonary intravascular macrophages of pigs with PPE. The primary 
site of these accumulations was identified as the pulmonary capillary endothelial cells as 
early as 2 d after initial FB, exposure (102). It was speculated that the membranous material 
could be result of damage to the intracellular network as a result of sphingoid base 
accumulation (18). 
1.3.6.3.1. Specificity of FB induced pulmonary edema 
The role of species and organ specificity ofFB,-induced endothelial 
alterations in PPE was examined by Gumprecht et al (103). Pigs were fed FB, -contaminated 
feed at a concentration high enough to provide a dosage of 21 jimol FBi/kg BW/d for 3 d or 3 
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Hmol FBi/kg BW for 5 wk. Changes in pulmonary capillary endothelial cells were also 
examined in dosed sheep (28 pmol FBi/kg BW directly into the abomasum), rabbits (1.8 
gmol FBi/kg BW, IV, single dosage) and rats (1.8 gmol FBj/kg BW, IV, single dosage). 
Microscopic evaluation of changes was performed in lung, liver, heart and kidney of all 
species. The results of the study indicated that FB-induced lesions were only observed in 
pulmonary capillary endothelial cells of pigs and not in other tissues or species examined. 
The observed changes were similar to those previously described by Gumprecht et al (102). 
1.3.6.4. Hepatotoxicity 
Fumonisins cause hepatic injury in all sensitive species regardless of the route of 
exposure. Hepatic injury is generally dose- and time- dependent and is manifested by 
elevated activity of hepatic enzymes -markers of liver injury- such as aspartate 
aminotransferase (AST), y-glutamyltransferase (GGT) and alanine aminotransferase (ALT) 
(104). Presumably, cell membranes of hepatocytes in FB-exposed animals are severely 
damaged, allowing the intracellular enzymes to leak into the bloodstream and increase its 
levels in serum. The damage observed in cell membranes of hepatocytes might be due to the 
sphingoid base accumulation and decrease of membrane complex sphingolipids induced by 
FB|. In addition, affected animals usually develop jaundice due to accumulation of bilirubin 
in the system caused by damage to the hepato-biliary system. Serum biochemical changes 
indicate hepatic necrosis, cholestasis, and decreased hepatic function. According to Wang et 
al (77), elevated serum enzymes indicative of liver damage are preceded by elevation of the 
Sa/So ratio indicating that disruption of sphingolipid metabolism in tissues occurs previous to 
the onset of clinical signs and alterations in liver enzymes. Acute morphologic alterations in 
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FB-induced liver damage generally include disorganization of hepatic cords, hepatocellular 
vacuolation, megalocytosis, apoptosis, necrosis, and cell proliferation mostly in the 
centrilobular and midzonal regions of the liver (7, 18, 102). 
1.3.6.4.1. Hepatotoxicity in horses 
As mentioned earlier, other species of economical importance such as the 
horse may be affected by FB. Marasas et al dosed horses by stomach tube with 1.25 and 2.5 
g of F. moniliforme corn culture material/kg BW/d for 6 d (28). These animals developed 
mild to severe hepatosis characterized by midly swollen and discolored khaki-brown livers 
with slightly accentuated lobulation. Histological changes included marked cloudy swelling 
and hydropic degeneration, as well as necrotic and apoptotic hepatocytes. Disorganization of 
hepatic cords in the centrilobular and midzonal areas was also present. Riley et al observed a 
marked increase in liver enzymes after feeding horses 104 pmol FB^/kg of feed for a 48-d 
period (90). 
1.3.6.4.2. Hepatotoxicity in swine 
In general, pigs exposed to FB develop hepatic injury that is typically dose-
and time-dependent. Clinically, pigs with severe liver disease become anorectic and icteric, 
may have lower weight gain, show signs of hepatic encephalopathy, and become moribund. 
Liver damage is characterized by elevated serum markers of liver injury. Alterations in 
hepatic serum biochemical parameters include increases in serum bile acids, increased 
concentration of bilirubin, AST, GGT, lactate deshydrogenase and arginase activities at 
levels as low as 17 gmol FB,/kg of feed (17). Osweiler et al observed subacute 
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hepatotoxicosis in pigs administered IV 0.0011 pmol FBi/kg BW for 14 d (7). An increase 
above normal levels in AST, GGT and total bilirubin has been reported in swine exposed to 
FB dietary levels greater than 24 pmol/kg diet for more than 5 d (7, 17, 105, 106). An 
increase in total serum cholesterol is also a feature of FB-induced liver disease in pigs (18). 
Morphologic alterations have been observed in livers of pigs ingesting FBr-contaminated 
diets with levels of 24 gmol FBi/kg of feed for a 5-d period. Microscopic lesions usually 
consist of random hepatocellular necrosis and apoptosis, nuclear pleomorphism, distorted 
hepatocytes, hepatomegalocytosis and increased numbers of mitotic figures (7, 17). The 
majority of these changes in swine will be revisited in chapters 2 and 3 of this dissertation. 
1.3.6.4.3. Mechanistic role of fumonisin in hepatotoxicity 
Although the hepatotoxic effect of FB is well known, its mechanistic role in 
the pathogenesis of liver disease is currently under active research using rodent models. 
Studies done on the influence of the cytokine TNFa on FBi-induced hepatotoxicity have 
shed some lights. Bandhari et al administered mice both subcutaneously and orally, 36 |imol 
FBi/kg BW as a single dosage and sacrificed them from 0-24 h after treatment (107). The 
expression of TNFa was increased in both liver and kidney regardless of the administration 
route. The oral dose caused greater hepatotoxicity, characterized by increased serum liver 
enzymes. The increase in enzymes eight hours after oral administration correlated with the 
highest TNFa levels. The expression of interferon (IFN)-y was increased in liver at 4 h after 
oral FBi exposure. In general, this study suggested a possible combined role of TNFa and 
IFN-y in hepatotoxicity induction. However, another study found that the role of TNFa in 
hepatotoxicity may be paradoxical. Sharma et al concluded that FB,-induced increase of 
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liver enzymes was enhanced by deletion of TNFa or unchanged in mice lacking both TNFa 
receptors (108). Apparently, the presence of this cytokine was not necessary for FB,-induced 
hepatotoxicity in mice and a lack of its function may aggravate the hepatotoxic responses to 
FB, perhaps by preventing repair mechanisms or by increased expression of other signaling 
molecules. More research studies are necessary to clarify these findings. 
1.3.6.5. Nephrotoxicity 
Most of the studies on the toxic effects of FB in renal tissue have been performed in 
rodents. The kidney is thought to be one of the main target organs of FBi in these species, 
where it ultimately causes apoptosis and necrosis of renal tubule cells as well as an 
imbalance between cell loss and regeneration. This disequilibrium may be a significant 
contributor to carcinogenesis in rodents. In horses and pigs, histologic evidence of renal 
tubular injury has been inconsistently reported and could be secondary to severe hepatic 
injury, like the one observed in bile nephrosis (hepatorenal syndrome of unknown causes 
characterized by a decrease in kidney function in animals with a liver disorder) (18). This 
section intends to provide a brief review of the most significant findings in renal toxicity of 
FB] to date. 
Riley et al fed Sprague-Dawley rats 21, 69 and 208 gmol FB, for a 4-wk period to 
correlate ultrastructural changes with disruption of sphingolipid metabolism (79). The study 
also pursued a correlation among alterations in sphingolipid metabolism and light and 
electron microscopy in both liver and kidney. In the kidney, there were significantly elevated 
concentrations of sphinganine and the Sa/So ratio was increased at all FB, dose levels. The 
authors established a correlation between the urinary sphinganine and sphingosine levels and 
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the number of sloughed tubule epithelial cells in the urine. Light microscopy showed kidney 
tissues characterized by mild to marked vacuolation of tubule epithelium and individual cell 
necrosis or apoptosis of tubule cells. The severity of the lesions was proportional to the dose 
level. Suzuki et al evaluated the effect of FBi on specific renal markers in male Sprague-
Dawley rats daily injected intraperitoneally for a 4-d period with either 10 or 14 pmol FB,/kg 
BW (109). In both groups, protein excretion was increased and consisted primarily of high 
molecular weight moieties, which suggested increased glomerular permeability. Cationic 
and anionic transports were decreased by 40% and 75-80%, respectively. Microscopic 
lesions consisted of disseminated single-cell necrosis in proximal tubules with sloughing of 
cell remnants into the tubule lumen. Cells in the loop of Henle region showed hydropic 
degeneration along with locally increased cellularity in the glomerular mesangia. Since cell 
damage appeared to be minor, the authors suggested that the high molecular weight urinary 
proteins were of glomerular origin. An increase in urinary GOT was observed as a 
consequence of injury to the brush border membranes of the proximal tubules. The enzyme 
N-acetyl-P-D-glucosaminidase, a lysosomal hydrolase used to diagnose reduced glomerular 
filtration rate and structural damage to the proximal renal tubule, was elevated in urine 
during the final two days of the study, probably as a result of extensive cellular damage that 
would permit the contents of intracellular organelles to escape into urine. In another study in 
rodents, Bondy et al gavaged male Sprague-Dawley rats for an 11-d period with dosages of 
1.4-104 p.mol FBi/kg BW (110). Microscopic renal changes became evident at 1.4 pmol/kg 
BW and became more marked as the dose increased. Major changes were single cell 
necrosis and sloughing of tubule epithelial cells in the inner cortex, cytoplasmic basophilia, 
and epithelial cell atrophy. Elevated serum Ca2+ and Mg2+ were linked to a possible 
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reduction in glomerular filtration. An increase in levels of urinary protein may have reflected 
a combination of sloughing of tubule cells and increased glomerular permeability. 
In an extensive review of microscopic lesions observed in FB-induced rodent toxicity, 
Voss et al stated that as in liver, apoptosis is the initial microscopic lesion in kidney after FB 
exposure (111). According to this review, apoptotic cells are initially found almost 
exclusively in tubules of the outer medulla (corticomedullary junction) and many of the 
apoptotic cells appear rounded and detached from adjacent cells and the basement 
membrane. As the renal injury progresses, mitotic figures appear and the number of 
apoptotic cells increases in the tubule epithelium. If cytoplasmic vacuolation and basophilia 
are present, there will be decreased cellular height with alterations in nuclear size. At this 
point, lesions may extend deeper into the medulla or into the cortex, and epithelial cells are 
sloughed into the tubular lumen. Simultaneous cell loss and replacement observed at the 
cellular, histologic and gross levels may be a consequence of the failure of cell regeneration 
processes to keep pace with cell loss. As already mentioned, imbalances between cell loss 
and replacement in kidney tissue may be a significant contributor to carcinogenesis. 
1.3.6.5.1. Nephrotoxicity in rabbits 
Renal toxicity has also been observed in rabbits, which are a model often used 
in studies involving FB exposure. Gumprecht et al exposed a small number of rabbits IV to 
dosage levels between 0.2 and 1.4 pmol FBi/kg BW for a 4-5 d period (112). Lesions 
observed consisted of severe necrosis of proximal tubule epithelium in the outer stripe of the 
medulla and within the cortex. Individual cell necrosis and mitotic figures were common. 
Dilated tubules contained sloughed epithelial cells, protein, and granular casts in their lumens. 
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Interestingly, glomeruli appeared normal. LaBorde et al (113) also exposed rabbits to FB,. 
New Zealand White rabbits were daily dosed by gavage on gestation d 3-19 with dosages 
ranging from 0.3-2.4 pmol FB,/kg BW. Histopathological examination of 9 dead animals 
showed apoptotic cell death in hepatocytes and renal proximal tubule epithelium. The 
tubules also contained foci of vacuolated epithelium and regenerating epithelium as well as 
cell casts in the lumens. The glomerular mesangium appeared mildly thickened and 
hypercellular in most affected animals. 
1.3.6.5.2. Nephrotoxicity in swine 
In pigs, as mentioned earlier, most of the available data on renal function 
evaluation indicates that direct FB-induced nephrotoxicity is inconsistent in this species. 
Colvin et al intubated pigs with 22 pmol FBj/kg BW or fed 277 |imol FB,/kg of feed for up 
to 45 d. The animals developed PPE and liver necrosis but mild to moderate renal tubular 
necrosis (105). In Smith et al, pigs exposed to dietary FB dosages of <28 jamol FB/kg BW 
showed no indication of renal damage (96). This agrees with the results of the swine models 
detailed in the chapters 2 and 3 of this dissertation, in which obvious kidney damage was not 
present. 
1.3.6.5.3. Mechanistic role of fumonisin in nephrotoxicity 
The damage that occurs in renal cells after exposure to FB, has been recently 
addressed in vitro from a molecular standpoint. Johnson et al evaluated the increased 
susceptibility of porcine renal epithelial LLC-PK, cells that were incubated with FB, previous 
to treatment with the cytokine TNFa (114). Cells treated with TNFa showed a dose-
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dependent increase in apoptosis as well as an increase in DNA fragmentation and terminal 
uridine nucleotide end labeling in response to FBi exposure. The increase in DNA synthesis 
following TNFa treatment resulted in arrest of the Gz/M phase of the cell cycle. Flow 
cytometric analysis of the cell cycle confirmed that TNFa predominantly killed cells in the 
Gz/M phase. The activation of c-Jun N-terminal kinase (JNK), a mitogen-activated protein 
kinase (MAPK), was increased after 48 h of FB, exposure. MAPKs are known mediators of 
TNFa signal transduction leading to cell death or survival under various conditions. An 
increase in sphingoid base levels was also observed in treated cells. Overall, the results of 
this study suggested that FB] increased free sphingoid base levels and the population of cells 
in the G2/M phase. This population was shown to be most susceptible to TNFa-induced 
apoptosis. The authors speculated that phosphorylation of pro-apoptotic JNK might play an 
important role in this apoptotic mechanism in kidney cells. 
13.6.6. Cardiovascular toxicity 
Although not often thought as the primary cause of FB-induced characteristic 
diseases such as ELEM or PPE, cardiovascular changes caused by exposure to FB seem to 
play a determinant role in the pathogenesis of these animal ailments. The following 
discussion will address the relevance of these changes in horses and pigs exposed to FB. 
1.3.6.6.1. Cardiovascular toxicity in horses 
The cardiovascular changes associated with IV administration of I B, in 
horses were studied by Smith el al (115). Horses received IV injections of 0, 0.01 or 0.3 
pmol FBi/kg BW for a 7-28 d period. When neurological signs consistent with ELEM were 
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evident, evaluation of the cardiovascular system was performed. Changes included decreases 
in heart rate, cardiac output, right ventricular contractility, coccygeal artery pulse pressure, 
and pH and base excess in venous blood as well as increases in systemic vascular resistance. 
Fumonisin Bi-treated horses with and without clinical signs of neurological disease also had 
higher serum and right ventricular sphinganine and sphingosine concentrations than control 
horses. The study detected an association between FB]-induced leukoencephalomalacia, 
increased serum and myocardial sphinganine and sphingosine concentrations, and decreased 
cardiovascular function in horses. This work suggested that FBi-induced decreases in 
cardiovascular function may be associated with the pathophysiologic development of 
leukoencephalomalacia in horses. This hypothesis is currently under investigation. 
1.3.6.6.2. Cardiovascular toxicity in swine 
As discussed earlier, pulmonary edema is observed when pigs are exposed to 
sufficiently high levels of FB either IV or in the diet. As this lesion is often a consequence of 
cardiovascular damage, most of the early acute studies of FB exposure in pigs examined the 
cardiovascular system using pathological evaluation and electrocardiography techniques (99, 
105). Because alterations in the cardiovascular system were not detected in these early 
studies, interest in several later studies focused mostly on lung alterations as the cause of PPE. 
However, evidence of cardiovascular damage in pigs exposed to FB was soon found. Casteel 
et al (116) observed right ventricular hypertrophy and medial hypertrophy of small 
pulmonary arteries in a chronic study where pigs were fed 140-260 |imol FBi/kg of diet for 
up to 210 d. These chronic cardiovascular changes promptly stimulated the use of 
instrumented pigs to examine the effect of FB on this system through the measurement of 
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hemodynamic changes. Pigs that were fed Fusarium culture material-contaminated diets at 
<28 nmol FB/kg BW for a 3-7 d period as well as pigs administered 1.4 pmol FBi/kg BW/d 
for a 6-d period, showed increased mean pulmonary artery pressure and decreased heart rate, 
cardiac output and mixed venous oxygen tension (96, 98, 117, 118). In addition, treated pigs 
had decreased cardiac contractility as assessed by the maximal rate of change of left 
ventricular pressure (dP/dtmax) and end-systolic elastance, the gold standard in vivo measure 
of cardiac contractility (96, 97). Clearly, these series of studies identified the cardiovascular 
adverse effect of FB regardless of the route of administration and confirmed that PPE is 
probably caused by acute-left sided heart failure. The influence of elevated levels of 
sphingoid bases on cardiovascular changes has also been evaluated. Smith et al (99) exposed 
pigs to dietary FB dosages of <28 pmol FB/kg BW. Results showed that FB-fed pigs had 
plasma and cardiac tissue concentrations of sphingoid bases higher than control pigs within 
24 h of FB exposure. These concentrations continued to increase until the end of the study. 
The authors estimated that the onset of hemodynamic changes was associated with a plasma 
sphinganine and sphingosine concentrations of >2.2 mM and >1 mM, respectively. 
Moreover, as mentioned in the PPE section of this review, Haschek et al (18) proposed that 
an increased sphingosine level may inhibit the L-type Ca2+ channels of cardiac myocytes, 
thereby decreasing cardiac contractility. More recently, Constable et al exposed seven pigs 
to Fusarium culture material-containing diets at 28 pmol FB/kg BW for a 3-d period (119). 
Pigs were appropriately instrumented to measure ascending aortic pressure and flow, among 
other parameters. An increase in levels of sphingoid bases accompanied by decreased 
cardiac output and characteristic impedance as well as an increased vascular resistance were 
observed in the FB-exposed pigs. The study speculated that a possible sphingoid bases-
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mediated activation of TNFa, a cytokine previously mentioned that induces endothelium-
dependent and endothelium-independent vasodilation, could increase the concentrations of 
sphingosine in vascular smooth muscle. Therefore, TNFa-induced increased sphingosine 
concentrations in vascular smooth muscle could lead to vasodilation through blockade of L-
type Ca2+ channels. The study concluded that ceramide synthase blockade caused relaxation 
of systemic conduit vessels, which was accompanied by contraction of systemic resistance 
vessels, events all probably associated with the onset of PPE. 
1.3.6.7. Carcinogenicity 
Based on its mechanism of action, FB, fits the profile of a carcinogenic chemical. In 
fact, numerous studies in rodents have found evidence of its carcinogenic properties. The 
possible cancer-inducing effects of sphingolipid alterations by FBi were mentioned earlier in 
this dissertation. Fumonisin Bi is a probable carcinogenic agent in humans. This was 
confirmed when in 2002, the International Agency for Research on Cancer in Lyon, France, 
declared specifically FB] as a group 2B carcinogen or "possibly carcinogenic to humans" 
(10). Epidemiological data is available on the high incidence of esophageal cancer in the 
Transkei region of South Africa and several provinces of China. As mentioned in a previous 
section of this dissertation, high levels of FBi have been found in corn-based foods from 
these areas (32, 45-47). This section will briefly cover the experimental evidence available 
on the carcinogenicity of FB,. 
Marasas et al fed F. moniliforme culture material isolated from com in an area of high 
risk for  esophageal  cancer in Transkei ,  to  male BDIX rats  on a  l ife- long durat ion study (8) .  
At a dietary level of 8%, hepatic lesions in rats that died were characterized by cirrhosis, 
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nodular hyperplasia and bile-duct proliferation. At a dietary level of 4% for 286 d, followed 
by 2% for the rest of the experiment, diets were hepatocarcinogenic and caused 
hepatocellular carcinoma in 80% and ductular carcinoma of the liver in 63% of the surviving 
rats. Hepatocellular carcinomas in the experimental rats invariably developed in severely 
cirrhotic livers showing nodular hyperplasia. Basal cell hyperplasia was observed in the 
oesophageal epithelia of rats fed the culture material. 
Gelderblom et al identified Fumonisin B, as a tumor-promoting agent (9). Male BD 
IX rats were initiated with DEN and fed diets with either 5% F. verticillioides culture 
material or purified FBi for a 4-wk period. Rats that were fed 0.1% FB; developed GGT*-
altered hepatic foci whether they had been initiated with DEN or not, suggesting that FBi 
was a cancer-promoting agent. Lebepe-Mazur et al (120) studied the alteration in the 
persistence of placental glutathione S-trans ferase-po sit ive (PGST+) hepatocytes in female 
F344/N rats. The animals were fed a diet containing 28 jimol FB, from F. moniliforme/kg of 
diet for a 13-wk period with DEN being administrated to the rats at the end of the first week. 
After 12 wk, rats given DEN plus FB, developed 4-fold more PGST* hepatocytes than rats 
given DEN alone. In the same study, male and female F344/N rats were fed 28 (imol FB, 
from F. proliferatum/kg of diet for 1 wk before DEN treatment. Interestingly, there was a 
gender difference in the response of the animals. The results of the study suggested that FB, 
and unidentified F. proliferatum components reduced the persistence of DEN-initiated 
preneoplastic hepatocytes in males, and that F. moniliforme and F. proliferatum are 
cocarcinogens. This last conclusion would have been confirmed by combining FBi from 
both fungal species and feeding the mixture to male and female simultaneously. 
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The role of endogenous prostaglandins E% (PGEz) and Fia (PGFia) in FB, 
carcinogenesis was addressed in studies by Lu et al (J21) and Liu et al (122). In Lu et al, 
DEN-initiated Fisher 344/N rats that were fed 69 (imol FBi/kg feed for a 4-wk period 
showed greater amounts ofPGEa and PGFza as compared to animals fed 17 or 35 (imol 
FBi/kg feed. The authors concluded that because the elevations in prostaglandins paralleled 
the induction of AHF in the liver, an increase prostaglandin production might have been 
related to promotion of hepatocarcinogenesis in rats by FB,. A possible indirect effect of 
prostaglandins on the proliferation of tumor cells by suppressing the immune response (i.e. 
natural killer cells) in FB exposure was also suggested in this study. In Liu et al, DEN-
initiated F344/N rats that were fed 11 or 35 nmol FB,/kg feed for a 19-wk period showed a 
greater production of endogenous PGE% as compared to control group. Interestingly, only 
rats fed 35 pmol FB,/kg feed showed AHF induction in the liver, yet rats fed 11 p.mol FB,/kg 
feed also showed increased PGE% but no induction of AHF. The study suggested that the 
increase in prostaglandin production might have preceded the occurrence of preneoplasia. 
A confirmatory 2-year chronic carcinogenicity study was done by Howard et al (123). 
Female and male F344/N/Nctr BR rats and B6C3F,/Nctr BR mice were fed for two years a 
diet containing 0-139 pmol FB,/kg (female rats), 0-208 pmol FB,/kg (male rats), 0-111 nmol 
FB,/kg (female mice) and 0-208 jimol FB,/kg (male mice). Fumonisin B, was not 
tumorigenic in female F344 rats with dietary FB, levels as high as 139 jimol FB,/kg. Renal 
tubule adenomas and carcinomas were observed in male rats only at levels higher than 69 
pmol FB,/kg. Female mice showed hepatocellular adenomas and carcinomas at all dietary 
FB, levels. Tumor incidence in male mice was not affected by dietary FB,. This study 
clearly showed that FB, is a rodent carcinogen that induces renal tubule tumors in male F344 
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rats and hepatic tumors in female B6C3F] mice, adding a combined species-gender-
specificity notion to the carcinogenic effects of FBi in rodents. More research is essential to 
elucidate the causes of this phenomenon. The cellular origin of FBi-induced liver tumors 
was recently explored by Lemmer et al (124). The study found that 2-acetylaminofluorene 
(2-AAF), an alkylating agent that forms DNA adducts, potentiates the FB, induction of 
hepatocellular and cholangiocellular tumors in male F344 rats. The study concluded that the 
observed proliferation and neoplastic development of oval (liver progenitor) cells might have 
been the source of both types of tumors, presumably through the potent inhibitory effect of 2-
AAF on hepatocyte regeneration. 
1.3.6.8. Immunotoxicity 
Although the immunosuppressive effects of mycotoxins such as T-2 toxin and 
aflatoxin are well known, limited information is available regarding the effects of FB on the 
immune system. Changes in immune function induced by FB exposure appear to be non-
species specific and involve aspects of humoral, cellular, and innate immunity (125). The 
most significant findings to date will be addressed in this section. 
13.6.8.1. Immunotoxicity in rodents 
Tryphonas et al administered FBi to Sprague-Dawley rats by gavage at 1.4-35 
limol purified FB,/kg BW for 14 d (126). At the highest dosage level, 35 junol FB,/kg BW, 
rats showed decreased titers of T-dependent antigen sheep red blood cells as well as a 
significant increase in the number of colony-forming bacteria in the spleens of rats 
experimentally infected with Listeria monocytogenes. No adverse effects were detected on 
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spleen lymphocyte blastogenesis, Ca2+ mobilization in ConA-stimulated lymphocytes, 
natural killer (NK) cell activity, or peripheral blood monocyte phagocytic activity. 
According to Martinova and Merrill (127), FBi can be either immuno-stimulatory or 
immunosuppressive in mice depending on the dose of FBi and period of exposure. In 
general, it appears that mice are not as sensitive to FBi as rats. Mice fed 1.4-104 pmol 
purified FBi/kg of feed for 14 d showed minimal signs of immunotoxicity. A few females 
had mild thymic cortical lymphocytosis in the 48- and 104-gmol FBi/kg groups along with 
significant numbers of vacuolated bone-marrow cells including lymphocytes. No marked 
changes in the spleen or lymph nodes and no changes in the number of circulating blood cells 
or serum total immunoglobulins were observed (128). Some of the immunomodulatory 
effects of FB may be the result of changes in the expression of cell surface markers important 
in cell-cell communication. Martynova et al observed decreased CD3 receptor expression 
and sphingomyelin levels in thymocytes but not in splenocytes in mice after single IP 
injections of 7 or 28 jo,mol FB, (129). Immunomodulation may also be due to changes in 
cytokine expression. Peritoneal macrophages of mice injected subcutaneously with 0.35-9.4 
pmol FBi/kg BW/d for a 5-d period showed induction of TNFa mRNA and secretion of 
TNFa protein. However, INFy expression and secretion were unaffected (86). In a more 
recent study, mice fed diets containing 69 or 139 pmol FBi/kg were found to be more 
resistant to infection by a Brazilian strain of Trypanosoma cruzi than mice fed control diets 
(130). The study related the higher resistance to the parasite infection to a higher 
macrophageal nitric oxide production in mice fed FBi. The results of this work added to the 
perception of the variable effect of FB on the immune system of mice. 
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The immune response of rats exposed to FBi-reducing sugar products, the 
main component of the detoxification strategy discussed in this dissertation, has been 
evaluated in rats. DEN-initiated, Fischer344/N rats treated with 63 gmol FBi-fructose/kg of 
diet for 4 wk showed an increased tumor cytotoxicity of liver-associated NK cells against 
YAC-1 target cells, as compared to control or FBi-fed rats (121). The mechanism for the 
enhancement of tumor cytotoxicity of the FBi-fructose products was not clear. In contrast, 
the activity of hepatic NK cells was similar between DEN-initiated Fischer344/N rats that 
were fed for up to 19 wk with diets containing no FBi, highly purified FB| at 11 or 35 pmol 
FBi/kg of diet, or FB,-glucose containing a residual 11 pmol FBi/kg of feed, respectively 
(122). However, FBi -glucose-treated rats had significantly lower NKR-Plbright cells as a 
percentage of total liver-associated mononuclear cells than rats fed 35 gmol FBi/kg of diet at 
20 wk of age. NKR-Plbnght cells, along with NKR-Pldim and negative cells were the three 
NK cell populations identified by fluorescent staining of lymphoid cells in the study. An 
increased immunomodulatory effect of the FBi-fructose reaction products as compared with 
FB;-glucose products in rats would be worth exploring. 
1.3.6.8.2. Immunotoxicity in swine 
As mentioned earlier, limited information is available regarding the effects of 
FB on the immune system of swine. Short-term ingestion of corn screenings at 127 pimol 
FB|/kg of material for a 21-d period affected specific immunity in pigs to a very low extent 
(7). In that study, microscopic evaluation of tissues in pigs affected by PPE revealed that 
alveolar septa were minimally infiltrated by mononuclear cells and neutrophils with some 
alveoli containing a few mononuclear cells. Gumprecht et al (131) studied the FB effects on 
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the specific and nonspecific immunity in pigs after vaccination with the pseudorabies virus 
vaccine (PrV). The study found that animals fed 3 jxmol FBi/kg BW/d for a 5-wk period 
showed no significant changes in the PrV stimulation index, response to phytohemagglutinin, 
PrV antibody titers or total lymphocyte number. Similarly, no changes were found in CD3+, 
CD4+, CD8+, or CD4+/8+ subpopulations. Clearly, results indicated that FB did not affect 
either the cell-mediated or humoral response immune responses. The accumulation of 
membranous material found in pulmonary intravascular macrophages and Kupffer cells, and 
to a lesser extent in alveolar macrophages suggested an effect of FB on the function of 
macrophages (99). Pulmonary intravascular macrophages are the primary cells responsible 
for clearing particulates from the circulation in swine. Phagocytosis by alveolar 
macrophages was investigated using flow cytometry of fluorescein isothiocyanate-labeled 
opsonized Salmonella typhimurium in an in vitro study by Gumprecht et al (132). Results 
evidenced a dose-dependent FBi inhibition of S. typhimurium phagocytosis by a murine 
monocyte/macrophage (RAW264) cell line exposed to > 25 mM FB, for a 24-h period. In 
the same study, phagocytosis of S. typhimurium was decreased in alveolar macrophages 
from pigs fed FBi from culture material before the onset of PPE. Altogether these results 
evidenced the immunosuppressive effect of FBi in certain immune cell lines. 
1.3.6.9. Developmental toxicity 
The most recent important development in the toxicology of FB is the proposed 
association between consumption of high dietary FBi levels and the incidence of neural tube 
defects in humans due to inhibition of folate transport in nervous tissue cells. A summary of 
the research conducted on that association will be presented later in this section. 
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Lebepe-Mazur et al examined the fetotoxic effects of FBi in pregnant F344/N rats 
(133). The dams were orally dosed between d 8 and d 12 of gestation with 42 or 83 |imol 
purified FB|/kg BW/d or with 83 jimol FB; from F. proliferatum culture material/kg BW/d. 
In dams receiving the highest FB; dosage, relative litter weight was suppressed. Fetuses 
showed suppressed ossification of the strenebrae and vertebral bodies. In a later study, the 
embyotoxic potential of HFB; was tested in cultured rat embryos by Flynn et al (134). 
Gestation d 9.5 embryos were exposed to 0-300 pM HFB, for 45 h. At levels of 100 pM and 
higher, suppression of growth and overall development as well as a high incidence of neural 
tube defects (NTD) were observed. The study concluded that compared to previous findings, 
HFB; was a 100-fold less toxic than FB; in cultured rat embryos. 
In the early 1990s, a NTD outbreak that occurred among Mexican-American women 
in Cameron County, Texas, USA, triggered research studies on the possibility that exposure 
to FB-contaminated food during gestation may have contributed to these birth defects (11). 
The link between FB; and NTD had previously been investigated by Stevens and Tang (135). 
Their in vitro study showed that the folate receptor-mediated transport of 5-
methyltetrahydrofolate was blocked in cells with a 40% reduction in sphingolipid levels. 
These findings were confirmed by preventing neural tube defects with supplementation of 
folic acid in FB;-exposed mice embryos (136). In a rat model, hypomyelination produced by 
FB; in the brain was similar to the effects of starvation in rat pups prematurely removed from 
the dams during the postnatal period, suggesting that hypomyelination could be due to a 
deficiency in nutrients such as folate (13 7). A recent extensive review by Marasas et al 
suggested that FB consumption is a risk factor for human NTD and related birth defects such 
as craniofacial abnormalities (12). The authors stated that this is especially true when other 
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risk factors such as genetic susceptibility and limited availability of dietary folate are present. 
Three factors support a strong FB-low dietary folate-NTD association: the FB, mechanism of 
action as disrupter of sphingolipid metabolism, data on the embryotoxic effects of FB, in 
rodents, and the incidence of NTD in countries such as South Africa, China and Guatemala 
(Torres and Riley, unpublished data), where consumption of FB-contaminated foods is high. 
Further research on this association is warranted. 
1.3.7. Detoxification of fumonisin 
The detoxification method addressed in this dissertation, the non-enzymatic browning 
reaction between FB and glucose, constitutes an essential portion of this research work. This 
section will provide details on that reaction and other FB-detoxification strategies that have 
been explored in the literature. 
A number of different physical, chemical and biological strategies to reduce the 
concentration of FB in foods have been evaluated. Physical decontamination of corn by 
removing fines and screenings (<3 mm) from whole com kernels lowered FBi concentration 
but did not completely eliminate it (138, 139). Wet milling of naturally FB, contaminated 
com resulted in no detectable levels of the toxin in the starch fraction but it was found in 
steep water, gluten, fiber and germ fractions (140). Atmospheric pressure/ambient 
temperature ammoniation of F. verticillioides culture material reduced the FB content but not 
its toxicity when fed to rats (141, 142). Nixtamalization, the traditional treatment of com 
with calcium hydroxide and heat, used to produce masa flour to make tortillas, was suggested 
to decontaminate FB-contaminated com as almost no FB could be detected in com foods 
made with masa (43). In a later study, nixtamalization was found to reduce the FB 
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concentration of the corn but not the toxicity when fed to rats, probably due to toxic effects 
of HFB i, a chemically-modified fumonisin formed by this process (143, 144). Heat 
treatment of dry FB; contaminated com and rain-soaked pelleted mixed feed reduced 
detectable FB, but was not able to eliminate it (145, 146). Heat treatment was found to 
reduce FBi concentration in aqueous model systems in which HFB, was formed and the rate 
and extent of FB, loss increased with increasing temperature (147). Roasting resulted in 
almost complete reduction of detectable FB but it was not possible to determine if FB was 
either destroyed or undetectable (148). Deamination of FB, was assayed by Lemke et al 
(149). Removal of the primary amine group via diazotization in an aqueous solution under 
acidic conditions (pH 1) and low temperature (5 °C) with the addition of sodium nitrite 
resulted in substitution of the NHz of FB, group by a hydroxyl (OH) group. Results of an 
aquatic toxicology bioassay on the cnidarian species Hydra attenuata showed that 
deaminated FB, had decreased toxicity in comparison to the parent FB,. It would be 
interesting to explore this detoxification strategy in dietary animal models such as rodents. 
The high acidity required by this chemical reaction could raise concerns about the feasibility 
of this strategy. The effects of extrusion cooking on the recovery of FB, were tested by 
HPLC analysis of the FB, amine. Results showed more apparent loss of the FB, amine in 
samples processed with heat generating-mixing screws and than with non-mixing screws. 
The brown color of samples suggested that loss of FB, might be due to the NEB reaction 
(150, 151). The chemical characterization and the in vivo FB detoxifying effects of the NEB-
type FB-reducing sugar (i.e. fructose, glucose) reaction products have been studied in several 
references that will be discussed in a separate section of this dissertation. Separate 
subsections will also be dedicated to detoxification strategies previously explored such as 
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ammoniation, nixtamalization as well as to more recent ones such as adsorbent material and 
flavonoid treatments. 
1.3.7.1. Ammoniation 
Atmospheric ammoniation of corn has been used as an effective detoxification 
method for anatoxins in com, peanuts and cottonseed (152, 153). Due to its success in 
detoxifying aflatoxin, decontamination of FB by treatment with ammonia was investigated in 
com foods. Norred et al looked at the effects of ammoniation of com either cultured with or 
naturally contaminated by F. moniliforme in rats (154). Levels of FB, were reduced by 30 
and 45% in the culture material and naturally FB,-contaminated com, respectively. The 
toxicity of the culture material was not affected by ammoniation as weight gain, serum liver 
enzymes and histopathological lesions were similar between rats fed the ammoniated 
material and animals fed FB-contaminated, non-ammoniated diets. Voss et al also tried this 
detoxification strategy in male Sprague-Dawley rats (142). Diets contaminated with FB, 
from F. moniliforme at levels of 137 pmol FB,/kg were as toxic as ammoniated diets at 104 
Hmol FB,/kg. Despite failure of ammoniation to detoxify FB,, a recent study by Chourasia 
found FB, reductions of 30 and 40% in F. moniliforme culture material and naturally FB,-
contaminated com, respectively, after ammoniation (155). This study only confirmed what 
was already known about ammoniation of FB,-contaminated com. 
1.3.7.2. Nixtamalization 
This traditional process to produce masa or tortilla flour has been used for centuries in 
Central America to improve the nutritional value by increasing niacin bioavailability in the 
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masa (138). This process has also been suggested to decontaminate FB-contaminated corn 
(43). Nixtamalization consists of treating the FB, -contaminated com with calcium hydroxide 
(CaOHi, alkaline hydrolysis) and heat to hydrolyze the tricarballylic acid esters of FB, 
(Figure 1) and subsequently reduce the concentration ofFBi in foods. As mentioned before, 
the product of this treatment is hydrolyzed FB, (HFB,), which toxicity has been addressed in 
several studies. Hendrich et al cancer-initiated male F344/N rats with DEN at 10 d of age 
(144). At weaning, rats were fed F. proliferatum fermented com with (14 (xmol HFB,/kg) or 
without (69 [xmol FB,/kg) nixtamalization and nutrient supplementation for a 4-wk period. 
Although changes were not as severe as in rats fed non-nixtamalized com, animals fed 
nixtamalized feed had decreased weight gain, increased relative liver weight, plasma 
cholesterol and GGT concentrations. Rats consuming nixtamalized feed plus nutrient 
supplementation developed hepatocellular adenomas in levels similar to those in animals fed 
the FB, diet without nutrient supplementation. The study suggested that nixtamalization was 
not a useful detoxification strategy and that dietary HFB, toxic effects may be nutrient-
related. Voss et al fed male rats diets either containing nixtamalized F. moniliforme culture 
material at 80 jimol HFB,/kg or non-nixtamalized material at 98 pmol FB,/kg for a 4-wk 
period (156). Serum chemical and histopathological findings confirmed that the 
nixtamalized material was nephrotoxic and hepatotoxic, similarly to the non-nixtamalized 
diet. Clearly, these two studies suggested that nixtamalization is not an effective FB, 
detoxification treatment. 
The fate of FB, in nixtamalized FB-contaminated com foods has been recently 
evaluated in processed foods. Dombrink-Kurtzman et al treated FB,-naturally contaminated 
raw com at 12 gmol FB,/kg with lime to make tortillas (157). After processing, FB, level 
was 0.7 gmol /kg (18.5% of starting level), whereas HFBi concentration was 0.5 junol /kg. 
This study did not really contribute any new findings, just confirmed that the FBi level could 
be decreased with alkaline cooking of foods. Voss et al found that FB; is removed from corn 
and diverted into liquid and waste byproducts during the industrial production of tortilla 
chips (158). This implicates that those waste byproducts would have to be properly handled 
according to environmental regulations at corn foods industries. The reduction in the 
concentration of FBi in tortillas made using the traditional method of Mayan communities in 
Guatemala was evaluated by Palencia et al (159). A 50% of the total FBi plus HFBi was 
detected in the residual lime water and water washes of the nixtamal. When cell cultures 
were treated with extracts of tortillas, levels of sphinganine were lower than in cells treated 
with extracts of non-nixtamalized FB i -contaminated corn. According to this study, HFB, did 
not inhibit the enzyme ceramide synthase in cell cultures. It would be interesting to try to 
replicate these findings in an in vivo experiment by addressing the possible inhibition of 
ceramide synthase by HFBi. De La Campa et al (160) found that the amount of residual FB, 
detected in nixtamalized masa and tortillas cooked by traditional methods at Cameron 
County, Texas, decreased as the concentration of CaOH% increased. Increasing boiling times, 
however, did not have an apparent effect. This would suggest that the HFB, yield of the 
alkaline hydrolysis of FB, would be higher if the CaOHa level and reaction temperature are 
increased in the process. Longer cooking times would not have a significant effect on FB, 
concentration as the FBi-CaOH2 reaction is probably faster as the reaction temperature 
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1.3.7.3. Adsorbent materials 
Other non-traditional FB detoxification strategies have been recently investigated. 
Solfirizzo et al tested adsorbent materials such as cholestyramine, celite, bentonite and 
activated carbon; for their in vitro and in vivo capacity to adsorb FBi (161). Cholestyramine 
is a highly charged quaternary ammonium resin which effectiveness is claimed to be due to 
its anion exchange capacity and its capacity to physically entrap FB in a polymeric matrix. 
The in vitro capacity of the adsorbent materials to bind FB, was tested by incubating 1 mg of 
each adsorbent with 1 mL of water solutions containing FB, concentrations from 5-360 mM 
at 25 °C for 1 h. A separate study was designed to feed Wistar rats diets containing 50% 
FB,-contaminated feed (8 and 28 pmol total FB/kg of diet) and 50% feed mixed with 20 mg 
of cholestyramine/g of diet. The in vitro experiments showed that cholestyramine had the 
best absorption capacity (85%) as compared to activated carbon (62%) and bentonite (12%). 
Results of the animal study showed that the cholestyramine-treated rats consistently showed 
reduced Sa/So ratios in urine and kidney as compared to rats fed untreated FB,-contaminated 
feed. A recent study investigated the application of adsorbent agent technology in the 
removal of FB, from malt extract (162). Concentrations of 0.5-4% of hydrated sodium 
calcium aluminosilicate (HSCAS), a widely commercially available absorbing agent, and 
Egyptian montmorillonite (EM), an experimental adsorption agent, were incubated with 7, 14 
and 70 p.M FB, aqueous solutions for 1 h at 25 °C to test FB, adsorption capacity. In 
addition, the adsorbent materials at a level of 0.5% (w/v) were added to FB,-contaminated 
malt extract samples at 0.07, 0.14 and 0.28 (iM FB,, followed by incubation at RT for 30 min. 
The FB, adsorption ratio of HSCAS in aqueous solutions ranged from 84.7 to 92.4% of the 
total FB, present in the samples, whereas EM showed an adsorption ratio from 78.2 to 92.2%. 
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In malt extract samples, the HSCAS adsorbing capacity ranged from 88.2 to 91.9%. 
Adsorption capacity of EM ranged from 88.2% to 92.5%. The study speculated that EM 
could be used as an effective tool at entrapping carry-over FB, in the beer and general 
beverage as well as in food or pharmaceutical industries. As in vivo studies on the 
effectiveness of adsorbent materials in detoxifying or lowering the levels of FB in foods have 
shown inconsistent results, their use as a powerful detoxification strategy will require much 
more supporting and conclusive scientific data. 
1.3.7.4. Flavonoids 
Similarly to the goal of the two research studies presented in this dissertation, a 
strategy aimed at protecting BALB/c mice exposed to FBi against liver damage with a 
flavonoid mixture, silymarin, was designed by He et al (163). Silymarin is an extract from 
seeds and fruits of the plant Silybum marianum, commonly named "Blessed Milkthistle" 
(164). It contains a mixture of flavonoids such as silibinin, isosilibinin, silidianin, and 
silichristin; and is described as a suppressing agent of the activation of caspases and nuclear 
factor KB in various cells following TNFa treatment. He at al reported that this flavonoid 
mixture prevented FB,-induced overexpression of TNFa in pig kidney epithelial LLC-PK, 
cells, effectively protecting the cells against FB, cytotoxicity (163). In the silymarin-
BALB/c mice study, female animals were treated with 750 mg/kg silymarin by gavage and 
3.11 pmol FB,/kg subcutaneously for a 3-d period. Results indicated that silymarin 
significantly lowered the FB,-induced accumulation of plasma ALT and AST, indicators of 
liver injury, as well as the number of apoptotic hepatocytes while augmenting hepatocyte 
proliferation. Interestingly, silymarin potentiated FB,-induced accumulation of free 
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sphinganine and sphingosine in both liver and kidney but prevented the FBi-induced 
increases in TNFa, TNF receptor 1, TNF receptor-associated apoptosis-inducing ligand, 
lymphotoxin P, and INTy. This study clearly demonstrated that silymarin did not act directly 
upon the FBi molecule or inhibit the binding of FBi to ceramide synthase in the de novo 
sphingolipid synthesis pathway. Instead, silymarin prevented liver damage in these mice by 
inhibiting the biological functions of free sphingoid bases and increasing cellular 
regeneration. The dosage of silymarin needed to see the protective effect seemed too high 
(750 mg/kg) and could raise drug safety concerns. Effects of long-term sphingoid base 
accumulation are unknown. Chronic toxicity studies are needed to clear the safety of this 
compound. 
1.3.7.5. Nonenzymatic browning reaction 
As mentioned earlier, the toxicity of the products of this FB detoxification reaction 
were tested in the research studies that will be presented in chapters 2 and 3 of this 
dissertation. Detoxification of FB] by blocking the amine group with a reducing sugar such 
as fructose or glucose via the non-enzymatic browning (NEB) or Maillard reaction was 
suggested by Murphy et al (138). The Maillard reaction is a common reaction in foods 
between primary amines and reducing sugars under the influence of heat (63). The 
requirements for this reaction are a primary amine (from FBi), a reducing sugar such as 
fructose, glucose or lactose; heat and water at pH>7 (138). Once the reaction undergoes the 
dehydration step of the Schiffs base, the FB-reducing sugar adducts presumably cannot be 
regenerated to their original substrates, accounting for the chemical stability of the FB-
reducing sugar reaction products (Figure 4). 
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Figure 4. Proposed nonenzymatic browning reaction scheme of fumonisin B, and D-glucose 
based on positive electrospray ionization mass spectra and the lysine and D-glucose 
nonenzymatic browning reaction scheme of Yaylayan and Huyghues-Dcspointes (165). 
Letters correspond to FBi (A), FB,-glucose Schiff s base (C), jV-(carboxymethyl)-FB, (D), 
iV-(3-hydroxyacetonyl)-FBi (E), iV-(2-hydroxy, 2-carboxyethyl)-FB, (F). Taken from Lu et al 
(166). 
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1.3.7.5.1. In vivo studies on FBi-reducing sugar adducts 
This detoxification strategy was used to demonstrate a significant reduction in 
cancer promotion of DEN-initiated, Fischer344/N rats treated with 63 pmol FBi-fructose/kg 
diet when compared to rats fed 63 |a.mol FBi/kg of diet alone for 4 wks (129). The animals 
fed FBi-fructose products showed lower plasma levels of cholesterol, ALT, and endogenous 
hepatic prostaglandin production. Placental GST+- and GGT+-AHF occurred only in FBi-fed 
rats. The activity of liver-associated NK cells was significantly increased only in rats fed 
FB,-fructose products, which indicated an immune-enhancing effect of the FBI-fructose 
adduct. The remaining FB, in FB,-fructose diet was not specified in this study. Another rat 
study compared four groups of DEN-initiated Fischer rats fed diets containing no FB,, 11 
timol FB,/kg of diet, 35 jimol FB,/kg of diet or FB, reacted with glucose containing a 
residual 11 p. mol FB,/g of diet, respectively. The group fed 35 (imol FB,/kg of diet 
presented a high Sa/So ratio that indicated an alteration in the synthesis of complex 
sphingolipids, whereas Sa/So ratios ofFB,-glucose and control rats were not different from 
each other. In addition, FB,-glucose products prevented the promotion of 
hepatocarcinogenesis in DEN-initiated rats. This was evidenced by the absence of PGST+-
and GGT+-AHF as well as a lower endogenous hepatic prostaglandin E% production, a 
hallmark of hepatocarcinogenesis promotion in rats fed FB, (122). Howard et al looked at 
the toxicity of one of the FBi-glucose reaction products in female B6C3F mice (167). N-
carboxymethyl-fumonisin B, was found to be nontoxic in mice fed diets at 140 [imol/kg diet. 
This was evidenced by the lack of alteration in weight gain, serum total bile acids, 
cholesterol, alkaline phosphatase and the liver Sa/So ratio in mice fed the FB-glucose product 
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as compared to mice fed FBi alone. There was no evidence of FB]-induced pathological 
lesions in mice fed the FB-glucose product. 
The efficacy of the FBi-reducing sugar reaction products in detoxifying FB, cannot 
be explained by a lower bioavailability. As mentioned before, works by Hopmans et al (63) 
and Dantzer et al (64) demonstrated that FB,-fructose and ^C-FB,-fructose adducts are 
approximately 9-fold more extensively absorbed than FB, and 14C-FB,, respectively, after 
oral administration in rats. 
The studies presented in chapters 2 and 3 of this work will provide more data on the 
efficacy of the FB,-glucose products, specifically in pigs. 
1.3.7.5.2. Chemical characterization of FB,-glucose products 
The probable products of the NEB reaction between FB, and D-glucose have 
been chemically characterized in several studies. Lu et al developed a method to separate 
hundred milligrams quantities of FB,-glucose products from the excess D-glucose using a 
reversed C,g cartridge (166). After reacting FB, with D-glucose at 60 and 65 °C for 48 h, 
several products of the reaction were determined by mass spectrometry analysis. These 
products were jV-carboxymethyl-fumonisin B,, N-( 1 -deoxy-D-fructos-1 -yl) fumonisin B,,TV-
methyl-fumonisin B], 7V-(3-hydroxyacetonyl)-fumonisin B,, and A/-(2-hydroxy, 2-
carboxyethyl)-fumonisin B,. In addition, this study also indicated that the FB,-glucose 
reaction followed apparent first-order kinetics as well as reductions of 30-35% in FB, 
fluorescence achieved when 139 mM FB, was reacted with 100 mM glucose at 60 and 80 °C 
using a corn model. This study was the basis of the FB-glucose intraperitoneal and dietary 
swine models to be presented in this dissertation. Two of the products characterized by Lu et 
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al (166), jV-carboxymethyl-fumonisin Bi and N-( 1 -deoxy-D-fructos-1 -yl) were also 
characterized in other studies (168, 169). 
1.3.8. Statement of the research problem and hypothesis 
The economical implications of the exposure of swine to FB may be great. As stated 
in this literature review, the toxic effects of FB in this species may include, depending on the 
exposure level, the occurrence of fatal PPE in acute doses, or liver damage in subacute or 
subchronic doses. Testing of the efficacy of the FB-glucose detoxification strategy in swine 
was the main goal of the research papers presented in the following chapters 2 and 3 of this 
dissertation. The first study describes the effects of purified FBi-glucose products in swine 
using acute and subacute IP doses ofFBi. The hypothesis was that the chemical reaction of 
FB, with glucose would decrease FBi toxicity in swine. The second study describes the 
effects of dietary total FB-glucose reaction products in swine. The hypothesis tested was that 
the chemical reaction of FB with glucose in the diet would decrease the mycotoxin toxicity in 
swine. 
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2.1. ABSTRACT 
Acute and subacute intraperitoneal doses of fumonisin Bi (FBi) were administered to 
test the efficacy of the FBi-glucose reaction products in detoxifying FBi in swine. In the 
acute study at 11 pmol FBi/kg body weight, five of 6 pigs administered FB, and four of 6 
pigs administered FBi-glucose died from acute pulmonary edema. Analysis of weight gain, 
serum aspartate aminotransferase and y-glutamyltransferase, total cholesterol and 
pathological evaluation did not provide evidence of protection against FBi toxicity by the 
FB,-glucose reaction products. In the subacute study at 5.5 pmol FBj/kg body weight, one 
pig administered FBi died from liver damage. Analysis of serum aspartate aminotransferase, 
y-glutamyltransferase and total bilirubin showed protection against FB, toxicity by the FB,-
glucose reaction products. The levels of sphinganine and sphinganine/sphingosine ratios in 
serum and liver as well as pathologic findings, provided definitive evidence of protection 
against the FBi toxic effects by this detoxification procedure (p<0.05). 
Keywords: Fumonisin B,, fumonisin Bi-glucose, detoxification, swine. 
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2.2. INTRODUCTION 
The fumonisins are a group of mycotoxins mainly produced by the fungi Fusarium 
verticillioides (= F. moniliforme) and F. proliferatum in corn (1). Among other structurally 
related homologues, fumonisin Bi (FBi) is the most abundant natural contaminant of corn-
based products intended for human or animal consumption throughout the world (2). This 
mycotoxin has been associated with a high incidence of human esophageal cancer in some 
regions of China and the Transkei in South Africa, where corn-based foods are the staple diet 
(J). Hence, FB, has been declared a class 2B carcinogen, a probable human carcinogen (4). 
Fumonisin B, has species-specific toxic effects. In rodents, FB, is hepatocarcinogenic, 
hepatotoxic, and nephrotoxic (5). Horses are the most sensitive species known developing 
leukoencephalomalacia (ELEM) after consuming corn contaminated with FB, at levels 
greater than 0.001 jxmol/g (6, 7). In pigs, subacute dietary levels, in the range of 0.1 pmol 
FB,/g, can cause liver disease in about 15 d while acute dietary levels > 0.14 pmol FB,/g, 
may produce fatal porcine pulmonary edema (PPE) in less than one week (8, 9). In the 
United States, widespread large-scale outbreaks of ELEM and PPE occurred during the fall 
of 1989 and the winter of 1990. Significant numbers of horses and pigs died from 
consuming commercial mixed feeds containing FB, -contaminated corn (10). 
Fumonisin B, disrupts sphingolipid metabolism by potently inhibiting the enzyme 
ceramide synthase (sphinganine N-acetyltransferase) in the de novo biosynthesis pathway of 
major sphingolipids thus causing a rapid increase in free sphinganine (Sa), one of the base 
precursors (11, 12). The levels of free Sa and sphingosine (So) in tissues and biological 
fluids may be compared by constructing a ratio of Sa to So (Sa/So ratio) that is used as an 
early biomarker of exposure to the mycotoxin (13). The inhibition of ceramide synthase is 
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also likely to disrupt overall sphingolipid metabolism and theoretically, sphingolipid-
mediated regulation of important cell events such as apoptosis and mitosis, which are 
probably in part responsible for the cytotoxic and carcinogenic properties of the mycotoxin 
(11, 14). 
In swine, the animal model used in the present study, FB] alters sphingolipid 
biosynthesis with the greatest alterations in Sa and So concentrations occurring in kidneys, 
liver, lungs and heart (13). In a recent swine study, diets that were amended with a fungal 
culture of F. verticillioides to achieve FB, concentrations of 0.006 pmol/g and 0.01 nmol/g, 
caused a significant increase in the Sa/So ratio at d 15 and 8 of the study respectively (15). 
Serum markers of liver injury, such as aspartate aminotransferase (AST), y-
glutamyltransferase (GGT), total bilirubin and total cholesterol, increase after exposure to 
either acute or subacute levels of FB,. Hepatic lesions consist of apoptosis, necrosis and 
hepatocyte proliferation (8, 9). The toxicological effects of feeding 0.04 pmo] FB,/g of feed 
to weaned piglets for 28 d were recently evaluated. Animals presented typical signs of 
pulmonary edema with reduced feed consumption and weight gain as well as typical gross 
and microscopic lesions. Increases in erythrocyte count, hematocrit, total bilirubin, total 
protein, total cholesterol, and activities of serum alkaline phosphatase (SAP), AST and 
alanine aminotransferase (ALT) were detected (16). 
The primary amine group of FB, has been suggested as the site of toxicity for the 
molecule (17, 18). Detoxification of FB, by blocking the amine group with a reducing sugar 
such as fructose or glucose via the non-enzymatic browning (NEB) or Maillard reaction has 
been suggested (19). This detoxification strategy was used to demonstrate a significant 
reduction in cancer promotion of diethylnitrosamine (DEN)-initiated, Fischer344/N rats 
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treated with FB,-fructose when compared to rats treated with FBi alone (20). The effect of 
extrusion cooking on the chemical recovery of FBi was tested by HPLC analysis of the FBi 
amine. Results showed more apparent loss of the FBi amine in samples processed with 
mixing screws and heat generated than with non-mixing screws. The brown color of samples 
after extrusion suggested that loss ofFBi might be due to the NEB reaction (21, 22). The 
products of the FBi-glucose chain reaction were recently characterized as TV-car bo xymethyl-
fumonisin Bi (23,24), N-( 1 -deoxy-D-fructos-1 -yl) fumonisin Bi,iV-methyl-fumonisin Bi, N-
(3-hydroxyacetonyl)-fiimonisin Bi, and jV-(2-hydroxy, 2-carboxyethyl)-fumonisin Bi ( 24). 
A recent study compared three groups of DEN-initiated Fischer rats fed diets 
containing no FBi, highly purified FBi at 0.03 pmol FB,/g of feed and FB, reacted with 
glucose containing a residual 0.01 pmol FBi/g of feed respectively. The Sa/So ratio in the 
FBi-glucose group was the same as the controls whereas the FB, group presented a ratio that 
indicated an alteration in the synthesis of complex sphingolipids (25). 
This study describes the effects of FB,-glucose reaction products in swine using acute 
and subacute intraperitoneal (IP) doses of FB, in completely randomized designs. 
Toxicological endpoints were defined as PPE and liver damage respectively. Our hypothesis 
was that the chemical reaction of FB, with glucose would decrease FB, toxicity in swine. 
The goal was to evaluate the efficacy of the FB,-glucose reaction products in detoxification 
of acute and subacute FB, poisoning of swine. 
2.3. MATERIALS AND METHODS 
Preparation of purified fumonisin B,. Liquid cultures of Fusarium proliferatum strain 
M5991 were prepared following the method of Dantzer et al (26), by inoculating capped 
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baffled Erlenmeyer flasks containing 500 mL of modified Myro medium with a 4 d shake 
flask culture of the fungus for 100 d. Fumonisin Bi was isolated and purified to >95% 
according to the procedure of Dantzer et al (27). Preparation of fumonisin B,-glucose 
adducts. Two batches of FB,-glucose adduct were prepared according to the method by Lu 
et al (24). Briefly, 1.39 mM FB, (total = 6.144 mmol or 4.435 g in the acute toxicity study 
and 2.061 mmol or 1.488 g in the subacute toxicity study) were mixed with 0.1 M D-glucose 
and dissolved in 50 mM potassium phosphate buffer, pH 7.0. After incubating at 80 °C for 48 
h for the acute toxicity study and 200 h for the subacute toxicity study, the pH of the reaction 
mixture was adjusted to pH 2.7 with 2 N HC1 to stop the reaction. The reaction was 
conducted for a longer time in preparation for the subacute toxicity study to achieve 89% free 
amine FB, reduction by glucose. High capacity CI8 SPE cartridges (Alltech, Deerfield, IL) 
were preconditioned with 50 mL of 100% methanol at pH 2.7 followed by 100 mL of 
deionized water at pH 2.7. An aliquot of 50 mL of the 1.39 mM FB,-0.1 M D-glucose 
reaction mixture was loaded onto the cartridge. The cartridge was washed with 100 mL of 
deionized water and 100 mL of 30% methanol at pH 2.7. The excess D-glucose was washed 
out in this step. The FB,-glucose was eluted with 50 mL of 40% methanol and 100 mL of 
100% methanol at pH 2.7. The eluent was evaporated to dryness with a Brinkmann 
rotavapor R110 (Westbury, NY) at 37 °C. The percentage of free and reacted FB, were 
determined according to Dantzer et al (27). For the acute toxicity study, the residue was 
redissolved in 0.9% sterile saline to obtain an FB, concentration of 11 pmol/mL. For the 
subacute toxicity study, the residue was redissolved in sterile 0.05 M potassium phosphate 
buffer pH 7.35 to achieve an FB, concentration of 5.5 (imol/mL. We used potassium 
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phosphate buffer in the subacute toxicity study after we determined it would improve the 
solubility of the FBi-glucose residue compared to saline solution. 
Experimental animals. The use of animals and experimental procedures were 
approved by the Iowa State University Laboratory Animal Care Committee in 2000. In the 
acute toxicity study, eighteen 3-week old healthy pigs with initial body weights between 6.2 
and 7.7 kg, were randomly assigned to three treatment groups (6 pigs/treatment), housed in 
groups of two per pen and allowed to acclimate to the animal room for three days. Room 
temperature was maintained at 27 °C with water and feed supplied ad libitum. In the 
subacute toxicity study, twelve 3-week old pigs with initial body weights between 4.9 and 
8.6 kg, were divided into similar treatment groups (4 pigs/treatment), individually housed in 
pens and exposed to the same conditions as in the acute toxicity study. 
Experimental treatments. All doses were administered IP once a day. Volume 
injected never exceeded 1 mL/kg BW to minimize abdominal discomfort. Treatments 
consisted of the vehicle, FBi and the FBi-glucose reaction products (FBi-G). In the acute 
toxicity study with PPE as endpoint, doses were administered for a maximum of 9 d and 
were, in the control group, 1 mL vehicle/kg BW; in the FBi group, 11 fimol FBi/kg BW; and 
in the FBi-G group, 11 |xmol FBj-G/kg BW. The FBj-G products contained approximately 
30% unreacted FBi determined by HPLC and ELISA=3.3 gmol FBi/kg BW. In the 
subacute toxicity study with liver damage as endpoint, doses were administered for a 
maximum of 7 d and were in the control group, 1 mL vehicle/kg BW; in the FBi group, 5.5 
pmol FBi/kg BW; and in the FBj-G group, 5.5 jxmol FBi-G/kg BW. The FBj-G products 
contained approximately 11% unreacted FB, determined by HPLC=0.6 pmol FBi/kg BW. 
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Diet. All pigs in the acute and subacute toxicity studies received the same balanced 
diet consisting of weaning feed (Nevada Feed & Seed Co., Nevada, IA) with the following 
proximate composition: dry matter (88.8%), protein (18.76%), lysine (1.35%), fat (4.74%), 
fiber (3.22%), calcium (0.91%), phosphorus (0.75%), salt (0.55%), zinc (139.4 ppm), iodine 
(0.02 ppm), iron (19.8 ppm), copper (0.9 ppm), manganese (3.42 ppm), selenium (0.28 ppm) 
and vitamin E (3.96 IU/kg). 
General health of the swine was evaluated using a checkup list form specifically 
designed to record simple clinical observation parameters including behavior, mucous 
membrane coloration, respiratory rate (resp/min), heart rate (beats/min) and rectal 
temperature (°C) on a daily basis. 
Weight gain was calculated on d 3 of the acute study and d 7 of the subacute study by 
subtracting initial body weight from final body weight. 
Clinical chemistry. In the acute toxicity study, blood samples were taken on d 0 and 
3 by jugular venipuncture. In the subacute toxicity study, pigs were bled from the orbital 
venous sinus on d 0,4 and 7. Blood was allowed to clot for at least 45 min and then 
centrifuged at 3100 rpm for 15 min to separate serum from the clot. All samples were 
evaluated for serum chemistry analysis. The liver enzymes aspartate aminotransferase (AST) 
and y-glutamyltransferase (GGT), total bilirubin (BIL) and total cholesterol (CHOL) were 
measured using a programmable, automated clinical analyzer (Hitachi 912, Roche 
Diagnostics, Basel, Switzerland). In the subacute toxicity study, duplicate serum samples 
were stored at -20 °C for extraction and HPLC analysis of sphingolipids. 
Sphingolipid analysis. The concentration of Sa, So and their ratio in serum and liver 
were measured only in the subacute toxicity study because tissues from acute toxicity study 
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were lost in a freezer failure. Extraction, internal standard curve and HPLC analysis were as 
follows. 
The method in appendix 1 of Riley et al (28) was followed with some modifications. 
All samples were analyzed in triplicates. Three hundred microliters of serum were added to 
1.2 ml of cold 0.05 M potassium phosphate buffer (pH 7.0) for homogenization. One 
hundred microliters of the solution were transferred to a 13 x 1000 mm acid-washed glass 
tube with a PTFE-faced, rubber-lined cap. Thirty microliters of 5 pM d,l-erythro-C20-
dihydrosphingosine (C-20, 150 pmoles) internal standard were added. Samples were stirred 
every 15 min during incubation. Centrifugation speed was 4000 rpm. The CHCI3 residue 
was dried at 37 °C under N2 using a nitrogen evaporator (Organomation Associates, INC, 
Berlin, MA) set. Samples were stored at 4 °C overnight. The next day, samples were base-
hydrolyzed and incubated at 37 °C for 1 h. Chloroform and alkaline water were added, then 
the samples were stirred and centrifuged at 4000 rpm for 15 min. The final CHCI3 residue 
was dried at 37 °C under N% using a nitrogen evaporator. Samples were stored at -80 °C until 
HPLC analysis. A C-20 internal standard curve was constructed for So and Sa analysis using 
C-20 as the internal standard. 
Samples were resuspended two hours prior to HPLC analysis with 300 pi of 85% 
methanol and 30 fxl of ethanol, stirred for 30 s and sonicated for 5 min. Twenty microliters 
of OP A were added followed by stirring for 30 s and sonication for 1 min. The samples were 
kept for 2 h at room temperature in a dark environment. Samples were transferred to a 0.45 
pm eppendorf nylon filter tube and centrifuged at 10000 rpm for 30 s in a microcentrifuge 
(Beckman Instruments, Inc., Fullerton, CA). Injection volume was 250 pL. The mobile 
phase consisted of HPLC-grade methanol (pump A, 85%) and 1% acetic acid (pump B, 
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15%). Flow rate was 1 ml/min with a run time of 15 min. The column used was a C-18 
reversed phase Dynamax 50 x 4.6 mm (Varian, Walnut Creek, CA) heated at 42 °C. A 
fluorescence detector was set at 335 nm emission and 440 nm excitation. 
Pathological evaluation. In the acute toxicity study pigs were necropsied on d 9, 
unless euthanized due to poor health or found dead. In the subacute toxicity study necropsies 
were performed on d 7. In both studies, pigs were euthanized with a lethal intravenous dose 
of 0.5 mL of 7.8% sodium pentobarbital solution. In the subacute toxicity study, weights of 
potential target organs liver, lungs, heart and kidneys were obtained and compared to final 
body weight to construct organ weight/body weight ratios. Tissue samples from organs were 
fixed in 10% neutral buffered formalin, processed routinely, sectioned at 5 pm, and stained 
with hematoxylin and eosin for histological evaluation. Additional tissue samples were stored 
at -20 °C for further sphingolipid extraction. 
Statistical analysis. Within-day comparisons of the least square means of the 
response variables between the three treatment groups were made by a repeated 
measurements analysis using SAS software V. 8.02 (SAS Institute Inc, Cary, NC, 2001). A 
P-value of 0.05 was considered as significant except where noted. 
2.4. RESULTS 
In the acute toxicity study, pigs in FBi and FBi-G groups received 11 jimol FB,/kg 
BW. The dose of free unreacted FB, in the FBi-G group was 3.3 fxmol FBi/kg BW 
representing a 70% free amine FBi reduction. No clinical signs were observed in any of the 
pigs on d 1 of the study. Five pigs in the FB, group and four in the FB,-G group died from d 
2 through d 6. Eight of the 9 pigs died acutely with clinical signs typical of PPE with 
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duration of less than 4 h. The ninth pig, from the FB, group, was mildly icteric and weak late 
on d 6 and was found dead early on d 7. From d 7 to d 9, the remaining pig in the FB, group 
and the two remaining in the FB,-G group were free of clinical signs of PPE except that one 
of the FB,-G pigs was moderately depressed with evident mild icterus of skin, sclera and 
mucous membranes. The control group had the highest weight gain, 1.2 ± 0.1 kg, whereas 
the FB, and FB,-G groups gained an average of 0.5 ± 0.14 kg and 0.7 ± 0.14 kg respectively. 
Weight gains of the FB, and FB,-G groups were not statistically different (p<0.05) (Figure 
1). 
On d 0 of the acute toxicity study, the serum levels of AST, GGT and total bilirubin 
were similar among the treatment groups (Table 1). Total cholesterol was moderately 
elevated in FB, and FB,-G pigs with respect to controls. On d 3, AST was moderately 
elevated in FB, and FB,-G pigs as compared to controls, GGT levels were similar among the 
treatment groups, total bilirubin was moderately elevated only in FB, pigs, and cholesterol 
levels were slightly elevated in FB, and FB,-G groups with respect to controls (p<0.05). The 
analysis of sphingo lipids could not be carried out in this study because the serum and liver 
tissue samples stored for this purpose were lost in a freezer failure. 
In the acute toxicity study, 5 FB, and 4 FB,-G pigs showed characteristic signs of 
acute PPE which included massive hydrothorax with abundant clear straw-colored fluid high 
in serum proteins within the thoracic cavity, and marked interstitial pulmonary edema with 
broad bands of gelatinous straw-colored fluid separating the major interlobular spaces. One 
additional FB,-G pig was determined to have died due to exanguination into the peritoneal 
cavity as a probable result of trauma from IP injection. Necropsy of the remaining pigs in the 
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FBi and FBi-G groups revealed no lesions of PPE, although, one pig in the FBi-G group 
showed mild icterus of skin, sclera and mucous membranes. 
In the subacute toxicity study, pigs in FB and FB,-G groups received 5.5 |imol 
FBi/kg BW. The dose of free unreacted FB, in the FB,-G group was 0.6 jimol FB,/kg BW 
representing an 89% free amine FB, reduction. The control pigs had no apparent signs of 
disease throughout the duration of the experiment. Pigs receiving FB,, on the other hand, 
showed weakness, rough hair and lateral recumbency by d 4. Their condition continued to 
worsen on a daily basis as they refused to eat and icterus became evident in the ventral 
abdominal and inguinal region of the body and in the ocular sclera. Early on d 7, one FB, 
pig was found dead. Three of four FB,-G pigs showed rough hair and mild weakness from d 
4 to d 7 but in general all pigs in this group were considered in good health until the end of 
the experiment. Pigs in the control group had the highest weight gain, 2.02 ± 0.28 kg, 
whereas pigs in the FB, and FB,-G groups gained only 0.2 ± 0.12 kg and 0.85 ± 0.51 kg 
respectively. Weight gains of FB, and FB,-G groups were not statistically different (p<0.05, 
Figure 1). 
On d 0 of the subacute toxicity study, the serum levels of AST, GGT, total bilirubin 
and total cholesterol were similar among the treatment groups (Table 2). On d 4, the FB, 
pigs showed moderately elevated AST and total bilirubin with respect to controls. GGT 
levels were similar among the treatment groups, and total cholesterol was lower in controls 
as compared to FB, and FB,G, which shared moderately elevated levels. AST and total 
bilirubin were highly elevated in FB,-treated pigs as compared to controls and FB,-G pigs on 
day 7. GGT was higher in the FB, group but to a lesser extent. Total cholesterol was higher 
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in FBi pigs followed by FB,-G and controls, with all groups different from each other 
(p<0.05). 
In the subacute toxicity study, serum So levels remained stable throughout and were 
not statistically different among the treatment groups at any time point (Table 3). On d 0, Sa 
concentration and the Sa/So ratio were similar between the treatment groups. On d 4, Sa 
concentration in FBi pigs was greater than in control but similar to FBi-G pigs. Control and 
FBi-G pigs results were not different from each other. The Sa/So ratio in FBi pigs was 
higher than in control but similar to FBi-G pigs, whereas control and FBi-G pigs had similar 
ratios. On d 7, the Sa concentration and Sa/So ratio were higher in FBi pigs as compared to 
control and FBi-G pigs, which results were not different from each other (p<0.05). In liver, 
So levels in FBi-G pigs were higher than in FBi and control pigs (Table 4). FB, pigs had 
lower levels of So than control and FB,-G pigs. The So concentration in control pigs was 
intermediate between FB, and FB,-G pigs. Levels of Sa were higher in FB, as compared to 
controls and FB,-G, which were not different from each other. The Sa/So ratio followed a 
trend similar to the Sa concentration (p<0.05). 
Gross inspection of the FB, pigs in the subacute toxicity study revealed severe yellow 
discoloration of subcutaneous, abdominal and pericardial fat. Lungs had a normal diffuse 
pink color, were not edematous and had clear airways and trachea. Pale-yellowish irregular 
areas could be observed in the liver, which did not appear enlarged. The surface of the 
kidneys appeared pale tan to grey and in some cases had a very congested cortex and very 
yellow-tinged renal papillae on cut surface. Serosal surfaces of the gastrointestinal tract 
appeared mildly congested and edematous but not hemorrhagic. FB,-G and control pigs 
showed no obvious icterus and were in general free of lesions. Microscopic liver changes in 
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the FBj group consisted primarily of mild to moderate, multifocal random necrosis of 
individual hepatocytes or small groups of hepatocytes with resultant disorganization of 
hepatic sinusoids. Hepatocytes individualized, became rounded or hypereosinphilic, and had 
pychnotic, karryorrhexic, or karryolytic nuclei. Mild to moderate karyomegaly was often 
observed in adjacent hepatocytes. A comparison of the three treatment groups is presented in 
Figure 2. In the FBi-G group, two of four pigs showed large, clear, well demarcated 
vacuoles in the distal nephron but were otherwise free of lesions. No microscopic lesions 
were observed in control pigs. Ratios of organ weight to total body weight for heart, lungs, 
liver or kidney showed no significant differences between the treatment groups (data not 
shown). 
2.5. DISCUSSION 
The acute toxicity study did not clearly demonstrate reduction ofFBi toxicity by its 
reaction with glucose in IP dosing of swine. This was shown by the death from acute PPE of 
five of 6 pigs in the FBi group, dosed 11 (imol FBj/kg BW, and four of 6 pigs in the FBi-G 
group, dosed 3.3 pmol FBi/kg BW. On day 3 weight gains were similar among the FB, and 
FBi-G groups, and the clinical parameters AST and total cholesterol were above normal 
levels (29) and not significantly different in pigs from these two groups. The toxic effects 
observed in this study were consistent with acute FBi toxicosis in swine and have been 
reported by several authors (30-34). The partial failure of the FB|-glucose adduct in 
protecting the pigs in the acute toxicity study from the effects ofFBi could be explained by 
the 30% free FBi in the FBi-G mixture. If this was the case, FBi-G pigs received an IP dose 
of approximately 3.3 fimol FB,/kg BW. This dose of FB; is significantly higher than the 
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intravenous (IV) dose level of 0.55 pmol FBi/kg BW used by Harrison et al (JJ) to 
characterize acute PPE. It is worthy to mention that on d 3 of the acute toxicity study, total 
bilirubin results in FB,-G pigs were within normal range (29), similar to results in the control 
group and lower than in the FBi group, providing some evidence of protection of the liver in 
the FBi-G group (Table 1). 
In contrast to the acute FB, dose, the subacute toxicity study revealed reduction of 
FBi toxicity in pigs. Only one pig died from apparent liver damage in the 5.5 pmol FBj/kg 
BW group while no pigs administered the FBi-glucose products at a dose of 0.6 nmol FBi/kg 
BW group died. We believe that two main factors, dose level and amount of free unreacted 
FB, in the FB,-glucose mixture, contributed to the success of the detoxification treatment in 
protecting the pigs from FBi-induced liver damage. The IP dose of 5.5 gmol FBi/kg BW 
was half the dose used in the acute toxicity study and the amount of free unreacted FBi in the 
FB;-glucose adduct was only 11%, meaning that FB;-G pigs received an FB; dose of 
approximately 0.6 gmol/kg BW. The high mortality observed in the FB;-G pigs of the acute 
toxicity study, which received 3.3 pmol FBi/kg BW, as compared to the FB, pigs of the 
subacute toxicity study, which received a dose of 5.5 pmol FBj/kg BW, could be explained 
by the toxicity of the FB;-glucose products. In preparation for the acute toxicity study, the 
FB;-glucose mixture was heated for 48 h, resulting in 70% free amine FB; reduction by 
glucose. Additionally, other reaction products that were not chemically characterized and 
which toxicity remains unknown may have also been formed. It is likely that these additional 
uncharacterized products in the acute toxicity study may have inhibited the enzyme ceramide 
synthase in the pigs treated with FB;-glucose, disrupting the sphingolipid metabolism and 
leading to left-sided heart failure and ultimately PPE. Although in the subacute toxicity 
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study the FBi-glucose products were prepared following the same method, the mixture was 
instead heated for 200 h, resulting in 89% free amine FBi reduction. The additional FBi-
glucose reaction products formed in the subacute toxicity study were not chemically 
characterized. However, we observed that these did not cause any obvious signs of toxicity 
in the pigs of the FBi-glucose group. Howard et al (36) fed female B6C3F mice 14, 70 and 
140 pmol/kg diet of several fumonisin derivatives, including FBi and TV-car bo xymethyl-
fumonisin Bi, one of the fumonisin Bi-glucose reaction products previously characterized 
(23, 24). The study found that only FBi was hepatotoxic while all other fumonisin 
derivatives did not alter serum analytes, organ weights or hepatic structure. The high 
mortality of pigs administered the FBi-glucose products in the acute toxicity study as 
compared to the pigs administered FB; in the subacute toxicity study could also be explained 
by a higher susceptibility to FB; exposure. The pigs used in the acute toxicity study were 
obtained from a different source than the pigs used in the subacute toxicity study, possibly 
having a different genetic background and a higher susceptibility to FB, at a 3.3 gmol/kg BW 
dose. In pilot studies not previously published we have exposed crossbred pigs to levels as 
high as 145 pmol FB;/kg diet and found no evidence of alteration in AST, GGT or total 
bilirubin. These findings contrast with the results of several studies (8, 9) that have found 
liver damage after feeding pigs diets containing less than 145 pmol FB;/kg, which lead us to 
believe that susceptibility to FB; could be different in pigs from different genetic lines. 
Harrison et al (35) reported the observation of pulmonary edema in pigs administered IV 
pure FB; at a dose of 0.55 pmol/kg BW for 4 d, a dose much lower than our IP dose of 3.3 
pmol/kg BW. Toxicokinetics of pure FB; after IV or IP administration appear to be 
comparable. Shephard et al (37) dosed rats IP with 10.4 pmol/kg BW of l4C-labelled FB; 
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and after 24 h recovered 66% of radioactivity in feces and 32% in urine. Prelusky et al (38) 
administered IV 14C-labelled FBi to pigs at a dose of 0.5 pmol/kg BW. After 72 h 58% of 
radioactivity was recovered in feces and 21% in urine. Although in different species, the 
toxicokinetics results from these two studies appear to indicate similar excretion of FB, after 
either IV or IP administration. 
The results of our subacute toxicity study agree with FBi data of Haschek et al (31), 
in which pure FB, administered IV to pigs at 0.0012 p,mol/kg and 0.0016 [xmol/kg BW for 9 
and 4 d respectively, caused mild intermittent respiratory signs but not pulmonary edema or 
severe liver damage. Osweiler et al (8) also observed subacute hepatotoxicosis in pigs 
administered IV 0.0011 pmol FB,/kg BW for 14 d. Our weight gain results were equivocal. 
Pigs in the FB,-G group had a weight gain similar to pigs in the FB, group. This observation 
is because two of 4 pigs dramatically decreased their feed consumption on d 4-5 of the study, 
causing the average weight gain to drop while the other two pigs consumed as much feed as 
the controls (feed consumption data not shown). Although we could not establish a clear 
explanation of this variability, experiment-related stress events may have contributed to it. 
We do not believe these two pigs had developed FB,-glucose adduct-induced feed refusal 
since two of 4 pigs ate well. In FB, pigs, the liver enzymes AST and GGT started to show a 
time-dependent elevation on d 4. By d 7, dramatic differences in the liver enzyme levels 
were evident between the FB, and control or FB,-G groups. This indicated that liver cells in 
the FB, pigs of the subacute study were severely damaged, allowing the intracellular 
enzymes to leak into the bloodstream, events that presumably did not occur in the control or 
FBi-G pigs. These findings are similar to the results of Liu et al (25) in which rats exposed 
to diets containing 0.011 or 0.034 pmol FB,/g for 12 or 20 weeks had significantly higher 
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plasma alanine aminotransferase (ALT) levels than rats fed a basal or FBi-glucose diet for 
the same period of time. Our results also agree with a study by Lu et al (20) in which rats fed 
0.07 nmol FBi/g of diet for 4 weeks had a significantly higher ALT level than rats fed 0.07 
pmol FBi/g of diet reacted with fructose for the same time. ALT is a specific enzyme for 
hepatocellular injury in small species, including the rat (39). Total cholesterol levels in 
control pigs showed a time-dependent decrease while levels in FBi-G pigs remained 
practically unchanged during the study. This pattern could explain the significant differences 
observed between control and FBi-G pigs at days 4 and 7 of the subacute study. 
Since FBi disrupts sphingolipid metabolism, results of individual levels of serum Sa 
and So and their ratio showed protection of the FBi-G pigs in the subacute toxicity study. 
The levels of Sa in particular, showed a time-dependent elevation in the FBi group 
throughout the study. On d 7, Sa levels and the Sa/So ratio were higher in the FB, pigs as 
compared to controls and FBi-G pigs. The higher Sa levels in the FB, group were what we 
expected. Several studies had previously found a significant elevation of Sa after feeding 
swine pure FB, at 0.002 pmol/g of diet for 5 d (40), FB, from culture material at 0.027 
|xmol/g for 1 day (41) or pure FB, at 0.013 pmol/g for 8 d (30). In contrast to Riley et al's 
findings (13), the serum Sa levels in the FB,-treated pigs of our study did not plateau before 
d 4 and the serum So levels did not continue to increase for the duration of the study. The 
levels of So were not different between the three groups throughout the subacute toxicity 
study, which agrees with Riley et al (13) and Gumprecht et al (30). Blocking of the primary 
amine group of FB, by its reaction with glucose likely prevented the inhibition of the enzyme 
ceramide synthase in the sphingolipids synthesis pathway. Therefore, accumulation of 
sphingolipids precursors Sa and So was not observed in the FB,-G group. A similar scenario 
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was observed in liver, where Sa levels were higher in the FBi group but not different 
between controls and FBi-G, resulting in Sa/So ratios that followed the same pattern. The 
results obtained from our FBi-treated pigs were similar to those of previous studies that have 
found increased liver Sa and to a lesser extent So, and elevated Sa/So ratios in pigs fed diets 
containing 0.031 |xmol FBi/g for 14 d (75) or 0.013 pmol FBi/g for 8 weeks (40). In 
addition, pharmacokinetic studies have shown a good correlation between the magnitude of 
sphingolipid alterations and the distribution of FB,, which is highest in liver and kidneys 
(#. 
Gross lesions in the subacute toxicity study agreed with a study by Colvin et al (33) in 
which pigs were daily gavaged with 5.5 and 22.2 pmol FBi/kg BW for 45 and 7 d 
respectively. In that study, pigs were also severely icteric, as was evident from the bright 
yellow color of the sclera, oral mucosa and subcutaneous adipose tissue. Livers had a tan 
coloration. However, Colvin et al (33) findings in kidneys were different from ours in that 
they found mild to moderate renal tubular necrosis and we did not. These researchers 
reported that lungs were normal and, although more severe than in our study, their pigs 
showed gastrointestinal lesions such as ulceration and erosion of the nonglandular mucosa. 
Microscopic changes consistent with both hepatocyte necrosis and apoptosis were observed 
in the FB, pigs of our subacute toxicity study. These changes matched those found in several 
dietary and IV studies (8, 31, 34). Interestingly, two of our FBi-G pigs had well-demarcated 
vacuoles in the distal nephrons. We believe this represented a random finding because the 
remaining two FBi-G pigs did not present such lesions and the other kidney structures were 
free of lesions. 
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In conclusion, in contrast to the acute IP dose of 11 pmol FBi/kg BW, the subacute IP 
dose of 5.5 prnol FBi/kg BW yielded clear evidence that derivatization of the FBi amine with 
glucose can protect the livers of pigs against the hepatotoxic effects ofFB,. Further studies 
are necessary to assess the use of this detoxification strategy in swine feed operations where 
quality might be adversely affected by FBi contamination. Its implementation in the field 
will depend on the use of appropriated processing equipment that would require additional 
research. 
2.6. ABBREVIATIONS USED 
ALT, alanine aminotransferase ; AST, aspartate aminotransferase ; BIL, total bilirubin; 
C-20, d,l-erythro-C20-dihydrosphingosine; CHOL, total cholesterol; DEN, 
diethylnitrosamine; ELEM, equine leukoencephalomalacia; FBi, fumonisin B,; FB,-G, 
fumonisin B,-glucose; GGT, y-glutamyltransferase; 
NEB, non-enzymatic browning reaction; OP A, o-phthalaldehyde; PPE, porcine pulmonary 
edema; Sa, sphinganine; SAP, alkaline phosphatase; So, sphingosine. 
2.7. SAFETY 
Fumonisin Bi is a class 2B carcinogen and was handled accordingly. 
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Legends to the figures: 
Figure 1. Comparison of weight gain between the three treatment groups in the acute (n=6) 
and subacute (n=4) studies. The error bar represents the standard error of the mean (SEM). 
Different letters above error bars indicate statistically significant differences between the 
treatment groups at a given time point (p<0.05). In both studies, average initial body weights 
(Day 0) did not differ significantly among the groups. 
Figure 2. Subacute study. (1) Liver from a fumonisin B%-treated pig with multifocal, 
individual hepatocyte degeneration and necrosis. This figure illustrates several degenerate 
hepatocytes with pyknotic nuclei (A) and nuclear karyorrhexis (B). (2) Liver from control 
pig. No significant microscopic lesions were observed. (3) Liver from a fumonisin B,-
glucose-treated pig. No significant microscopic lesions were observed. Hematoxylin and 
eosin stain. Bar = 30 |im. 
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Table 1. Aspartate aminotransferase (AST), y-glutamyltransferase (GGT), total bilirubin 
(BIL) and total cholesterol (CHOL) levels in serum on d 0 and 3 of the acute toxicity study. 
FBi dose: 11 jxmol/kg BW; free FB| in FB,-glucose dose: 3.3 pmol/kg BW" 
AST (IU/L) GGT (IU/L) BIL (mg/dL) CHOL (mg/dL) 
Day 0 
Control 37.8 ± 4.8 a 56.3 ± 5.3 a 0.18 ± 0.01 a 157.5 ±33.4 a 
FB, 51 ±6.7 a 62.5 ± 7.9 a 0.29 ± 0.04 a 213 ± 13.8 b 
FBi-G 42.7 ± 5.9 a 70+ 13.8 a 0.25 ± 0.04 a 242.3 ± 35.2 b 
Day 3 
Control 54 ± 9.3 a 55.3 ±2.1 a 0.19 ±0.01 a 84.7 ± 3.6 a 
FB, 191 ± 72.5 b 69.8 ± 7.5 a 1.11+0.33 b 136.8 ± 9.9 b 
FBi-G 174.2 + 62.7 b 76.6 ± 9.7 a 0.48 ±0.13 a 127.8 ± 17.2 b 
"The data are expressed as mean ± SEM. n=6. Different letters indicate statistically 
significant differences between the group means at a given time point (p<0.05). 
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Table 2. Aspartate aminotransferase (AST), y-glutamyltransferase (GGT) total bilirubin 
(BIL) and total cholesterol (CHOL) levels in serum on d 0, 4, and 7 of the subacute toxicity 
study. FBj dose: 5.5 nmol/kg BW; free FB, in FBi-glucose dose: 0.6 pmol/kg BW" 
AST (IU/L) GGT (IU/L) BIL (mg/dL) CHOL (mg/dL) 
Day 0 
Control 116 + 33.3 a 40.5 + 7.3 a 0.3 + 0.05 a 220.3 ± 22.9 a 
FB, 34 + 2.6 a 42 ± 3.7 a 0.2 ± 0.01 a 218.8 ± 12.4 a 
FB,-G 47.2 ± 15 a 45.5 ± 5.3 a 0.9 ± 0.26 a 245.8+ 18.6 a 
Day 4 
Control 63 ± 19.6 b 43.5 ±2.7 a 0.2 ± 0.02 a 104 ± 6 a 
FBj 201 +55 a 74.3 ± 7.3 a 2.3 ± 0.7 b 316.3 ±71.8 b 
FBj-G 48.5 ±11 b 56.3 ± 8.6 a 0.7 ± 0.23 a 252.5 ± 75.5 b 
Day 7 
Control 47.5 ± 8.4 a 37.3 ± 2.8 a 0.2 ± 0.01 a 85 ±6.1 a 
FB, 1804 ±661 b 128 ± 26.2 b 7.6 ±2.13 b 378.8 ± 57.5 b 
FBi-G 48.5 ± 6.9 a 48.3 ± 11.7 a 1 ± 0.45 a 274.5 ± 111.4 c 
"The data are expressed as mean ± SEM. n=4. Different letters indicate statistically 
significant differences between the group means at a given time point (p<0.05). 
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Table 3. Sphinganine (Sa) and sphingosine (So) (nmol/mL) and the Sa/So ratio in serum on 
d 0, 4 and 7 of the subacute toxicity study. FB, dose: 5.5 (xmol/kg BW; free FB, in FB,-
glucose dose: 0.6 jimol/kg BW" 
Sa (nmol/mL) So (nmol/mL) Sa/So 
Day 0 
Control 0.8 ± 0.2 a 12.4 ± 1.9 a 0.07 ±0.01 a 
(n=12) (n=12) (n=12) 
FB, 0.8 ± 0.2 a 9.3 ± 1.2 a 0.08 ± 0.01 a 
(n=12) (n=ll) (n=12) 
FBi-G 0.7 ± 0.08 a 10.5 ± 2.6 a 0.11 ±0.02 a 
(n=13) (n=13) (n=13) 
Day 4 
Control 0.92 ± 0.2 a 8.8 ± 1.2 a 0.11 ±0.03 a 
(n=12) (n=ll) (n=12) 
FB, 2.77 ± 0.9 b 8.25 ± 1.7 a 0.33 ± 0.07 b 
(n=12) (n=ll) (n=12) 
FBi-G 1.9 ±0.9 ab 9.88 ± 4.9 a 0.25 ± 0.05 ab 
(n=ll) (n=9) (n=12) 
Day 7 
Control 1 ±0.1 a 15.22 ± 2 a 0.05 ± 0.006 a 
(n=14) (n=8) (n=16) 
FB, 7.67 ± 2.5 b 26.57 ± 5.7 a 0.25 ± 0.07 b 
(n=10) (n=9) (n=10) 
O
 
à 2.02 ± 0.8 a 18.04 ±4.1 a 0.1 ±0.03 a 
(n-9) (n=7) (n=9) 
"Sphingolipids are expressed as nanomoles per milliliter of serum and expressed as mean ± 
SEM. Different letters indicate statistically significant differences between the group means 
at a given time point (p<0.05). 
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Table 4. Liver levels of sphinganine (Sa) and sphingosine (So) (nmol/g) and the Sa/So ratio 
in on d 7 of the subacute toxicity study. FBi dose: 5.5 pmol/kg BW; free FBi in FB,-glucose 
dose: 0.6 pmol/kg BW" 
Sa (nmol/g) So (nmol/g) Sa/So 
Control 0.1 ±0.05 a 45.1 ±4.1 ab 0.01 ± 0.008 a 
(n=8) (n=13) (n=6) 
FB, 13.7 ±2.1 b 37 ± 12.1 a 1.2 ± 0.4 b 
(n=12) (n=T0) (n=9) 
FBi-G 2.7 ± 0.4 a 71 ± 10.04 b 0.05 ± 0.01 a 
(n=13) (n-12) (n=12) 
"Sphingolipids are expressed as nanomoles per gram of liver tissue and expressed as mean 
± SEM. Different letters indicate statistically significant differences between the group 
means (p<0.05). Sa/So ratios between Control and FB, groups were different at a 10% 
significance level. 
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CHAPTER 3. FUMONISIN B-GLUCOSE REACTION PRODUCTS ARE LESS 
TOXIC WHEN FED TO SWINE 
A paper to be submitted for publication in the Journal of Agricultural and Food Chemistry 
Guillermo Fernândez-Surumay, Gary D. Osweiler, Michael J. Yaeger, George E. 
Rottinghaus, Suzanne Hendrich, Lucas K. Buckley and Patricia A. Murphy 
3.1. ABSTRACT 
Pigs were fed diets containing 528 pmol total fumonisin B/kg (FB), 528 fimol total 
FB-glucose/kg (FB-G, 122 ^mol unreacted FB/kg) or 0 |imol total FB/kg for 15 d to test the 
efficacy of the FB-glucose reaction products in detoxifying FB. Weight gain in FB pigs was 
lower than in FB-G or controls, which was correlated with feed intake reduction in FB pigs. 
Serum aspartate aminotransferase, y-glutamyltransferase and total bilirubin in FB pigs were 
higher than in FB-G or control pigs. Serum Sa/So ratio in FB pigs was higher than in FB-G 
or control pigs. Microscopic examination of tissues from FB pigs showed generalized liver 
necrosis and apoptosis with marked cellular pleomorphism and disorganized hepatic cords. 
Liver and kidneys in FB-G group appeared normal. Tissues of controls were free of lesions. 
The results suggest that dietary FB-glucose products could substantially protect swine in 
instances of widespread FB grain contamination (P<0.05). 
Keywords: Fumonisin B, fumonisin B-glucose, detoxification, swine 
3.2. INTRODUCTION 
Fumonisins (FB) are mycotoxins produced by fungi of the genera Fusarium, 
specifically F. verticillioides (==F. moniliforme) and F. proliferatum when weather conditions 
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are appropriate for FB production in com (/). Fumonisin B| (FBi) is the most common 
natural contaminant of corn-based foods worldwide (2). It has been associated with high 
incidence of esophageal cancer in the Transkei region of South Africa and some provinces of 
China, and recently declared a class 2B carcinogen or "possibly carcinogenic to humans" (3, 
4). In rodents, FBi targets the kidneys and liver, where it is capable of inducing 
hepatocarcinogenesis (5). Dietary FB; levels greater than 1 jxmol/kg may be fatal for horses 
causing equine leukoencephalomalacia ( 6, 7). In 1989, a large number of pigs died in the 
midwestem and southeastern parts of the United States, after being fed corn-based diets 
contaminated with fumonisins from that year's crop (8). A report by the World Health 
Organization in 2000 claimed that globally 59% of com or samples of corn-based products 
were contaminated by FB, (9). 
Swine exposed to subacute dietary levels of 40 pmol FB/kg for about 15 d may show 
feed intake reduction as well as lower weight gain (10). An increase above normal levels in 
the serum concentration of liver injury markers such as aspartate aminotransferase (AST), y-
glutamyhransferase (GGT) and total bilirubin has been reported in swine exposed to FB 
dietary levels greater than 24 ^.mol/kg diet for more than 5 d (11-14). Levels of total 
cholesterol typically increase significantly in pigs exposed to FB (8). Several studies report 
that dietary FB levels greater than 139 pimol/kg may be fatal for pigs, causing fatal porcine 
pulmonary edema (PPE) (8, 11). In swine, FB, disrupts sphingolipid metabolism by 
inhibiting the enzyme ceramide synthase (sphinganine N-acetyltransferase) in the de novo 
sphingolipid synthesis pathway. This leads to accumulation of the sphingoid base 
sphinganine (Sa) and to a lesser extent, sphingosine (So). The ratio of Sa to So (Sa/So ratio) 
may be used as an early biomarker of exposure in pigs fed or administered FB-containing 
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materials (15). Sphinganine concentrations increase in biological samples or tissues such as 
serum, liver, kidney, heart or lungs, when pigs are exposed to dietary levels in the range of 6 
|imol/kg for 15 d or 10 {imol/kg for 8 d (15, 16). Morphologic alterations have been 
observed in livers of pigs ingesting diets contaminated with FBi at 24 pmol/kg for 5 d. 
Microscopic lesions consist of random hepatocellular necrosis, nuclear pleomorphism, 
distorted hepatocytes, hepatomegalocytosis and increased number of mitotic figures (11, 14). 
The primary amine group in the FBi molecule has been described as the group 
responsible for the toxicity of the molecule (17, 18). Murphy et al (19) suggested that FBi 
could be detoxified by the formation of a FB]-reducing sugar adduct using the non-enzymatic 
browning (NEB) reaction. Preliminary cell tissue culture tests suggested that these adducts 
were less toxic than FBi (20). This strategy was later used in an animal study where 
diethylnitrosamine (DEN)-initiated Fischer344/N rats treated with FB,-fructose showed a 
significant reduction in cancer promotion when compared to rats treated only with FB, (21). 
The products of the FB,-glucose chain reaction were chemically characterized as N-
carboxymethyl-fumonisin B, (22, 23), N-(l-deoxy-D-fructos-l-yl) fumonisin B, (22, 24),N-
methyl-fumonisin B,, N-(3-hydroxy acetonyl)-fumonisin B,, and N-(2-hydroxy, 2-
carboxyethyI)-fumonisin B, (22). One of these products, N-carboxymethyl- fumonisin B,, 
was found to be nontoxic in female B6C3F mice fed diets at 140 pmol/kg diet (25). 
Promotion of hepatocarcinogenesis and hepatotoxicity were prevented in DEN-initiated 
female F344/N rats fed diets containing FB,-glucose at 35 |4.mol/kg with 33% unreacted FB, 
(11.1 jimol/kg) (26). In a more recent study, pigs were injected intraperitoneal^ with either 
5.5 p.mol FB,/kg body weight (BW), 5.5 gmol FB,-glucose products/kg BW (11% unreacted 
FB,=0.6 nmol FB,/kg BW) or 0.9% sterile saline once a d for 7 d. Results of weight gain, 
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liver injury markers and sphingolipid levels indicated virtually complete liver protection in 
pigs treated with the FBi-glucose reaction products (27). 
This study describes the effects of dietary FB-glucose reaction products in swine 
using a completely randomized experimental design. The toxicological endpoint was defined 
as liver damage. The hypothesis tested was that the chemical reaction of FB with glucose in 
the diet would decrease its toxicity in swine. The goal was to evaluate the efficacy of the 
FB-glucose mixture in detoxification of dietary subacute FB poisoning of swine. 
3.3. MATERIALS AND METHODS 
Animals. The use of animals and experimental procedures were approved by the 
Iowa State University Laboratory Animal Care Committee in 2003. Eighteen 3-week old 
crossbred healthy pigs, initial body weights between 5.7 and 6.9 kg, were housed in 
individual pens and allowed to acclimate to the animal room for 3 d. Room temperature was 
maintained at 27 °C and water and feed were supplied ad libitum. 
Treatments. Pigs were randomly divided in three treatment groups of 6 pigs each. 
Treatments were fiimonisin B (FB), fiimonisin-glucose (FB-G) and control. All pigs were 
daily fed 25% more feed than their typical intake to ensure enough feed availability. FB pigs 
were fed 528 pmol total FB/kg of diet (342 ^mol FBi/kg diet, 186 (imol FB^/kg diet). Pigs 
in the FB-G group were fed a diet containing nominal 528 pmol total FB/kg of diet with 
approximately 23% glucose-unreacted FB (122 |j.mol total FB/kg of diet). Levels of FBi and 
FB% were 79 pmol FBi/kg diet and 43 p.mol FB2/kg diet, respectively. Control pigs were fed 
0 pmol total FB/kg of diet. Based on the levels of dietary FB exposure and feed intake data, 
pigs in the control group received a daily average oral FB dosage of 0 pmol/kg BW, whereas 
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FB and FB-G pigs received dosages of 21.6 pmol/kg BW and 8.9 pmol/kg BW, respectively. 
All rations contained 20% moisture. 
Diets. All pigs received a balanced diet consisting of weaning feed (Nevada Feed & 
Seed Co., Nevada, IA) with the following approximate composition: dry matter (88.8%), 
protein (18.76%), lysine (1.35%), fat (4.74%), fiber (3.22%), calcium (0.91%), phosphorus 
(0.75%), salt (0.55%), zinc (139.4 ppm), iodine (0.02 ppm), iron (19.8 ppm), copper (0.9 
ppm), manganese (3.42 ppm), selenium (0.28 ppm), and vitamin E (3.96 IU/kg). This feed 
was the basis of the diet of all pigs in the study. 
Source of fumonisin B. Fusarium moniliforme Ml 325 com culture material 
containing 9,698 (imol total FB/kg (8,590 |xmol FBi/kg, 1,108 pmol FBz/kg) was obtained 
from the Veterinary Medical Diagnostic Laboratory at the University of Missouri. The 
material was appropriately mixed with clean weaning swine feed to obtain the target 
concentrations of FB in the rations. 
Fumonisin B-glucose adduct. It was prepared following the method by Lu et al (21) 
with major modifications. The amount of FB-glucose reaction products needed to obtain 1 
kg of feed at 528 (imol total FB/kg was prepared by adding 28.6 g of 9,698 gmol total FB/kg 
of F. moniliforme Ml325 com culture material (277 jimol total FB), 9.9 g of 99.7% food-
grade dextrose (54,939 gmol glucose) (ADM, Decatur, IL), 4.2 g of food-grade baking soda 
(49,940 fimol NaHCOg), and 200 mL tap water to a 500 mL autoclavable plastic container. 
The ratio FBrglucose was 1:200. The mixture was stirred for 45 min, its pH checked to be 
7.0 ± 0.2 and then autoclaved (121 °C, 30 psi) for 90 min. Following heat treatment, pH was 
measured again to confirm the buffering activity ofNaHCO). The mixture was allowed to 
cool down at room temperature and stored at 4 °C until mixed with 1 kg of weaning feed as 
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previously described. The diet of pigs receiving only FB was prepared by mixing the same 
amounts of F. moniliforme Ml325 com culture material, NaHCOj, and tap water but no 
glucose. In both cases, the final mixtures were HPLC-tested for unreacted FBi and FB% 
before and after autoclaving. 
General health. It was evaluated using a checkup list form specifically designed to 
record simple clinical observation parameters including behavior, mucous membrane 
coloration, respiratory rate (resp/min), heart rate (beats/min), and rectal temperature (°C) on a 
daily basis. 
Weight gain was calculated on d 15 of the study by subtracting initial (d 0) from final 
body weight (d 15). 
Clinical Chemistry. Pigs were bled from the orbital venous sinus on d 0, 5,10 and 
15. Blood was allowed to clot for at least 45 min and then centrifuged for 15 min to separate 
serum from the clot (International Equipment Company, Needham Heights, MA). All 
samples were evaluated for serum chemistry analysis. Liver enzymes AST and GGT; total 
bilirubin (BIL), and total cholesterol (CHOL) were measured using a programmable, 
automated clinical analyzer (Hitachi 912, Roche Diagnostics, Switzerland). Duplicate serum 
samples were stored at -20 °C for extraction and HPLC analysis of sphingolipids. 
Liver total cholesterol. All samples were analyzed in triplicates. Ten grams of liver 
were homogenized in 30 mL of 100% HPLC-grade methanol. A three mL aliquot of the 
homogenate was added 6 mL of 90% potassium hydroxide to disrupt the fatty acid ester 
linkages. Samples were refluxed for 30 min under a water cooled condenser. The mixture 
was allowed to cool down, 15 mL of distilled water was added and the solution was 
transferred to a separatory funnel. An equal volume (24 mL) of 100% HPLC-grade hexane 
130 
was added. The aqueous layer was washed with hexane three times. The three hexane 
fractions were pooled and evaporated to dryness in a rotoevaporator (Buchi, Switzerland). 
The cholesterol residue was redissolved in 1 mL of 100% ethanol by stirring and/or 
sonication and analyzed or stored at 4 °C until the next d. Samples were analyzed 
enzymatically using cholesterol oxidase (100 U/L), peroxidase (800 U/L), 0.25 mM 4-
aminoantipyrine, 10 mM hydroxybenzoic acid (Sigma, St Louis, MO), 50 mM potassium 
phosphate buffer (Fisher Scientific, Pittsburgh, PA) and 0.1% sodium azide (Eastman Kodak, 
Rochester, NY). A 30 pL aliquot of the redissolved samples in ethanol solution was mixed 
with 1.5 mL of the enzyme mixture, stirred for 30 s and incubated at RT for 1 h. The 
absorbance of samples was read in a DU 520 spectrophotometer (Beckman Instruments, Inc., 
Fullerton, CA) at 550 nm. A bovine brain cholesterol standard (Matreya, Inc., Pleasant Gap, 
PA) dissolved in ethanol was used to prepare standard curves. 
Sphingolipid analysis. The concentration of Sa, So and their ratio were measured in 
serum and liver. Extraction, internal standard curve and HPLC analysis were performed as in 
Femandez-Surumay et al (27). Thirty microliters of 5 pM t/,/-erythro-C20-
dihydrosphingosine (C-20, 50 pmoles; Matreya, Inc., Pleasant Gap, PA) internal standard 
were added to the samples during extraction. 
Pathological evaluation. All pigs were necropsied on d 15 after euthanasia with a 
lethal intravenous dose of 0.5 mL of a 26% sodium pentobarbital solution. Weights of 
potential target organs liver, heart and kidneys were obtained and compared to final body 
weight to construct organ weight/body weight ratios. Tissue samples from liver and kidneys 
were fixed in 10% neutral buffered formalin, processed routinely, sectioned at 5 pm, and 
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stained with hematoxylin and eosin for histological evaluation. Additional liver tissue 
samples were stored at -20 °C for further sphingolipid extraction. 
Statistical analysis. All tests were performed using SAS software V. 8.02 (SAS 
Institute Inc, Cary, NC, 2001). For each of the response variables AST, GGT, BIL, CHOL, 
serum Sa, serum So, serum Sa/So ratio, weight gain, and feed intake, within-day treatment 
comparisons of the least square means were made by a repeated measurements analysis using 
the MIXED procedure. For each response variable, the variance component of the 
RANDOM effects parameter (experimental subject nested in treatment) was estimated by 
method of moments. A compound symmetric covariance structure was assumed for each 
subject. Mean comparisons of response variables liver Sa, liver So, liver Sa/So ratio, and 
liver CHOL were adjusted with the Tukey method for multiple comparisons. A P-value 0.05 
was considered as significant except where noted. 
3.4. RESULTS 
We proposed that dietary FB-glucose reaction products would decrease liver toxicity 
in pigs fed subacute dietary levels of FB. In pigs receiving 528 (imol FB/kg diet, the clinical 
signs were mild to moderate and became obvious at d 4. These signs included weakness, 
rough hair and lateral recumbency. Icterus in skin of ventral abdominal and inguinal region 
was observed from d 10 to 15. The FB-G pigs, consuming 23% unreacted FB of a 528 (imol 
FB/kg diet (122 jxmol FB/kg diet) showed no apparent signs of disease, except for mild 
diarrhea in one pig on d 1 and 2. The control pigs (0 (imol FB/kg diet) did not show any 
apparent signs of disease throughout the duration of the study. No pigs died during the study. 
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The total average feed intake as percentage of body weight was statistically similar among 
controls (6% ± 0.6) and FB-G (6.2 % ± 0.4) pigs. Both groups had a higher feed intake than 
FB pigs (3.8% ± 0.3). As a result, FB pigs at d 15 had a significantly lower total weight gain 
(1.75 kg ± 0.61) as compared to controls (4.17 kg ± 0.58) and FB-G (5.1 kg ± 0.49) pigs, 
which were not different from each other (P<0.05) (Figure 1). 
On d 0 of the study, serum levels of AST, GGT, and total cholesterol were similar 
among the treatment groups (Table 1). Although the animals were randomly assigned to the 
experimental groups, total bilirubin was higher in controls as compared to FB-G pigs. In FB 
pigs, total bilirubin was similar to control and FB-G pigs. These differences were not related 
to the treatments and could have been due to stress events previous to FB exposure in the 
study. On d 5, FB pigs showed moderately elevated AST and total bilirubin with respect to 
controls. FB pigs had GGT levels higher than controls and similar to FB-G pigs, although 
not significantly elevated. Serum cholesterol was higher in FB and control pigs when 
compared to FB-G pigs, but not significantly elevated. On d 10, AST and total bilirubin 
were markedly elevated in FB pigs as compared to controls and FB-G pigs, which were not 
different. Levels of GGT and total cholesterol were also higher in FB pigs but to a lesser 
extent. On d 15, all AST, GGT, total bilirubin and total cholesterol showed markedly 
elevated levels in FB pigs as compared to controls and FB-G pigs, making the difference 
between FB pigs and controls and FB-G pigs even more pronounced (P<0.05). The total 
liver cholesterol levels in FB pigs (4.5 pmol total cholesterol/g liver ± 0.62) were 
significantly higher than in FB-G (1.95 ± 0.65) (P<0.05) and control pigs (2.64 ± 0.67) 
(P<0.1). Levels of controls and FB-G pigs were not different from each other. 
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The serum levels of Sa in FB pigs on d 0 were similar to that of control and FB-G 
groups while FB-G pigs showed Sa levels lower than in controls (Table 2). Serum levels of 
So and the Sa/So ratio were not different between the treatment groups. On d 5, Sa levels in 
FB pigs were higher than in control and FB-G pigs. Levels of So were similar between the 
treatment groups. Similar to Sa, the Sa/So ratio in the FB group was higher than in controls 
and FB-G pigs. On d 10, Sa levels were highest in FB pigs followed by FB-G and controls. 
The concentration of So was higher in FB and FB-G groups as compared to controls. The 
Sa/So ratio followed the same pattern as So levels. On d 15, Sa levels continued to be 
highest in the FB group followed by FB-G and control pigs. Levels of So were similar 
between the treatment groups while the Sa/So ratio, as Sa levels, was highest in the FB group 
followed by FB-G and control pigs (P<0.05). In contrast, liver levels of Sa and So were 
highest in FB pigs at necropsy followed by FB-G and controls (Table 3). The liver Sa/So 
ratio in FB pigs was higher than in controls but not different from the FB-G group. The liver 
ratios for control and FB-G pigs were not different from each other (P<0.05). 
On gross pathology inspection, five of 6 FB pigs showed icterus of subcutaneous, 
abdominal and pericardial fat. In one FB pig, yellow discoloration of these areas was not as 
severe. Livers of all FB pigs, although not enlarged, showed yellowish-tan irregular areas 
indicative of abnormal accumulation of bilirubin. Lungs had a normal diffuse pink color, 
were not edematous and had clear airways and trachea. Kidneys appeared normal on 
external and eut surfaces. Serosal surfaces of the gastrointestinal tract appeared midly 
congested but not hemorrhagic. Two of 6 FB-G pigs showed livers with pale-yellowish 
surface areas that did not appear irregular. The rest of FB-G pigs and all control pigs had no 
obvious signs of icterus and were apparently free of lesions. Microscopic liver changes in 
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FB pigs consisted of individual hepatocyte necrosis, shrunken hepatocytes with condensed 
chromatin indicative of apoptosis, disorganized hepatic cords and marked cellular 
pleomorphism with megalocytosis. No microscopic lesions were observed in kidneys of FB-
G or control pigs. Livers in the FB-G group appeared normal except for mild individual 
hepatocyte necrosis and disorganization of hepatic cords in the two FB-G pigs that showed 
pale-yellowish surface areas on gross evaluation. Tissues of control pigs were free of 
lesions. A comparison of the three treatment groups is presented in Figure 2. Ratios of 
organ weight to total body weight for heart, lungs, liver or kidney showed no significant 
differences between the treatment groups (data not shown). 
3.5. DISCUSSION 
In preparation for the present study, two preliminary dietary trials on the detoxifying 
effects of the FB-glucose reaction products in swine were performed. The goal of the first 
study was to determine the efficacy of these products on protecting pigs fed 97 p. mol total 
FB/kg diet with 19% unreacted FB (18 gmol total FB/kg diet) for a 25-d period against liver 
damage. Controls and FB pigs were fed 0 and 97 pmol total FB/kg diet, respectively, with 
three pigs in each group. We chose to feed 97 gmol total FB/kg diet based on previous 
studies in the literature in which liver damage was the endpoint (11-14). Our serum 
chemistry results indicated that a 97 |_imol total FB/kg diet level for a 25-d period was not 
sufficient to cause clinically recognizable liver damage in our FB pigs. The levels of liver 
injury markers AST (132 IU/L ± 27), GGT (58 IU/L ± 8) and total bilirubin (0.2 mg/dL ± 
0.04) at the end of the study were either within normal levels (28) or less than 1-fold higher 
than the upper normal limit. Since we were not able to induce liver damage at these FB 
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levels in these pigs, we could not demonstrate protection from the FB-glucose reaction 
products. To find out the appropriate dietary FB level to cause clinically recognizable liver 
damage, we designed a new pilot study in which four pigs were fed 396 and 528 pmol total 
FB/kg diet (2 animals/FB level) for a 16-d period. Decreased body weight gains and highly, 
elevated or above normal range average levels of AST (557 IU/L), GGT (185 IU/L), and 
total bilirubin (3.48 mg/dL) in pigs fed 528 pmol total FB/kg diet indicated severe liver 
damage. Hence, a total FB dietary level of 528 gmol/kg diet was selected for the study 
subject of this paper. 
In general, the data collected in the present study revealed that diets containing FB-
glucose reaction products at a concentration of 528 prnol total FB/kg diet with approximately 
23% unreacted FB (122 jxmol total FB/kg diet) dramatically diminished liver damage. 
Protection of FB-sensitive species by FB-fructose or FB-glucose adducts has been previously 
reported in rat (21, 26), mice (25) and swine (27) models. 
In the present study, total weight gain of FB pigs was significantly lower than that of 
FB-G or control pigs as a result of decreased feed intake. Significantly lower weight gains 
have been reported in swine exposed to diets containing 33 (J.mol total FB/kg for 14 d (10, 
14). 
The serum levels of liver injury markers AST, GGT and total bilirubin in pigs fed 528 
pmol total FB/kg diet with 100% unreacted FB were elevated above normal range (28) and 
were significantly higher than in pigs receiving FB-glucose products or control feed on d 10 
and 15 of the study. The levels of these markers have been previously reported to increase 
above normal levels in pigs exposed to dietary FB levels greater than 24 p.mol total 
fumonisin B/kg diet for more than 5 d (11-14). On d 15, however, FB-G pigs showed AST 
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and GGT levels above normal range and significantly higher than in controls but still lower 
than in the FB group. The difference between FB-G and control groups could be explained 
by the total unreacted-FB level in the diet of pigs in the FB-G group (122 pmol total FB/kg), 
which was considerably higher than in controls (0 |xmol total FB/kg). An alternative 
explanation is that the dietary FB-glucose reaction products in the diet of FB-G pigs could 
have induced mild liver damage characterized by a modest increase of AST and GGT levels. 
The FB-glucose products fed to the swine in this study have not been chemically 
characterized. A study by Lu et al (22) characterized the kinetics and products of the FBi-
glucose NEB reaction in a corn model system. One of the characterized products, N-
carboxymethyl-fumonisin B,, was fed by Howard et al (23) to female B6C3F mice at 14, 70 
and 140 pmol/kg diet. Results indicated that this FB derivative did not alter serum analytes, 
organ weights or hepatic structure in the mice. As we might hypothesize that one or more of 
the characterized FB-glucose reaction products could have been present in the diet of our FB-
G pigs, their individual toxicity remains unknown and should be object of future study. 
Levels of total cholesterol in serum followed the same pattern of total bilirubin. These were 
significantly higher and elevated above normal levels in FB pigs as compared to FB-G or 
control pigs. These results agree with Haschek et al (8), who described hypercholesterolemia 
as one of the most sensitive serum biochemical parameters of fumonisin exposure. 
The statistical differences in liver total cholesterol between the treatment groups were 
similar to those observed in the analysis of serum total cholesterol. Opossed to what we 
expected, liver total cholesterol was higher in FB pigs as compared to FB-G and control pigs. 
The enzyme hydroxymethylglutaryl-CoA reductase is described as the primary control point 
for cholesterol synthesis in the hepatocyte. Artificially increasing plasma cholesterol levels 
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in vivo decreased the activity of the enzyme in liver by repressing synthesis of the enzyme 
mRNA (29). This is consistent with Julius et al (30), who reported in their study of infant 
formulas and their effect on weanling pigs that liver cholesterol concentrations were 
inversely related to concentrations in plasma. However, the inhibition of the enzyme 
ceramide synthase in the pigs fed FB in this study could have affected the cholesterol 
metabolism in the liver. The bulk of cellular free cholesterol and sphingomyelin, one of the 
major sphingolipids which levels theoretically decrease after ceramide synthase inhibition, 
interact strongly with each other through hydrogen bonding and van der Waal's interactions 
to form cholesterol/sphingolipid-enriched domains or so-called "lipid membrane rafts" in the 
plasma and other organelle membranes (31, 32). The influence of sphingomyelin on the 
intracellular transport and metabolism of cholesterol and viceversa would not be surprising 
(33). We hypothesize that the inhibition of ceramide synthase in our FB pigs ultimately 
leaded to a decrease in the synthesis of cell membrane sphingomyelin, which could have 
activated the synthesis of cholesterol esters in the liver. This is supported by Chatteijee (34), 
who found an increase in cholesterol esters after reducing the levels of sphingomyelin by 
incubating human skin fibroblasts with the bacterial enzyme neutral sphingomyelinase. 
Moreover, in the present study the levels of sphingomyelin in the pigs fed FB could have 
been reduced even further by an increase in the levels of tumor necrosis a (TNFa). This 
cytokine has been found to increase the activity of sphingomyelinase in cultured human 
fibroblasts, and interestingly, has also been found in increased levels in macrophages 
exposed to FBi (34, 35). The possible complex interactions, if any, between FB, TNFa, 
sphingolipid and cholesterol metabolism in the liver remain to be studied. 
138 
It is well known that FB disrupt sphingolipid metabolism in swine. The results of 
serum Sa and Sa/So ratios indicated protection of the FB-G pigs. Blocking of the primary 
amine groups of FBi and FB% by their reaction with glucose likely prevented the inhibition of 
the enzyme ceramide synthase in the de novo sphingolipid synthesis pathway. Therefore, a 
significant accumulation of sphingolipid precursors Sa and So was not observed in the FB-G 
group. However, protection was not as evident as in the study by Fernândez-Surumay et al 
(27). In that study, pigs exposed to FBi-glucose reaction products at 5.5 jxmol/kg BW/d 
(=0.6 pmol FB]/kg BW/d) by intraperitoneal injection for 7 d, showed significantly lower 
serum and liver levels of Sa and a lower Sa/So ratio than pigs administered FBi at 5.5 
|i.mol/kg BW/d or control pigs. In the present study, pigs fed FB-glucose reaction products at 
528 [imol FB/kg diet had serum Sa levels and Sa/So ratios significantly lower than pigs fed 
FB at 528 jxmol FB/kg diet but higher than control pigs at d 15. As in the case of liver injury 
markers AST and GGT, this could be explained by the difference in total FB dietary levels 
between these two groups. In the present study, FB pigs received an average oral FB dosage 
of 21.6 pmol/kg BW/d, whereas FB-G pigs received 8.9 pmol/kg BW/d. According to 
Prelusky et al (36), the oral bioavailability ofFBi in swine is approximately 4.5%. If we 
apply this proportion to the average FB oral dosages in our study, FB and FB-G pigs 
absorbed an average of 1 and 0.4 (imol FB/kg BW/d, respectively. Considering only average 
daily FB dosages, in Fernândez-Surumay et al (26) a difference of 0.6 (xmol in the FB, 
dosage of FBi-G and control pigs was not sufficient to elicit different Sa level and Sa/So 
ratio responses in these two groups. In contrast, a difference of 0.4 pmol between the same 
groups in the present study caused higher Sa levels and Sa/So ratios in FB-G pigs as 
compared to controls, possibly caused by a higher susceptibility to FB in the pigs used in this 
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study. In general, a significant increase in the Sa/So ratio has been previously reported in 
pigs consuming diets with FBi concentrations of 13.9 (imol/kg diet for only 8 d (16, 37). An 
increase in the concentration of Sa and the Sa/So ratio has also been observed in pigs fed 32 
(xmol FBi/kg diet (15). In the present study, concentrations of Sa as well as the Sa/So ratio 
showed a time-dependent elevation in the FB and FB-G groups, which agrees with studies by 
Smith et al (38) and Gumprecht et al (39). The levels of So were not different between the 
three groups throughout the majority of the present study (d 0, 5 and 15). The difference in 
So levels observed on d 10 between controls, and FB and FB-G pigs was considered 
temporal as it disappeared on d 15. As we mentioned in the case of serum AST and GGT, 
another explanation for the difference in Sa levels and the Sa/So ratio between control and 
FB-G pigs could be that the dietary FB-glucose reaction products might have inhibited 
ceramide synthase, causing elevation of Sa and the Sa/So ratio in this group. Interactions 
between specific FB-glucose reaction products and the enzyme ceramide synthase in the 
sphingolipid biosynthesis pathway deserve further investigation. Liver levels of Sa and So in 
FB-exposed pigs were significantly higher than in pigs fed FB-glucose products or controls, 
which was indicative of protection by the FB-glucose products. This agrees with Fernândez-
Surumay et al (27), who reported a protective effect in Sa levels by FB-glucose products. 
Significant elevations of free Sa and So in liver have been previously reported in pigs fed 
diets containing 32 jxmol FB/kg diet for 14 d (15). As in the case of serum Sa on d 15, liver 
Sa and So were higher in FB-G pigs as compared to controls. As we mentioned before, this 
could be due to the FB level in the diet of FB-G pigs, inhibition of ceramide synthase by FB-
glucose products or both. In contrast to Fernândez-Surumay et al's findings (27), the liver 
Sa/So ratio in FB-G pigs, although lower than in FB pigs, was significantly higher than in 
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controls and statistically similar to those two groups. The higher values of Sa/So ratios 
observed in livers of FB-G pigs were likely a product of their high Sa liver levels as the ratio 
is a direct relationship between Sa and So levels (40). In general, the level of sphinganine 
appeared to be a more sensitive biomarker of exposure to FB than the Sa/So ratio in our pigs. 
Liu et al reached the same conclusion in their study on prevention of hepatocarcinogenesis 
promotion by FBi-glucose reaction products in rats (26). 
The lesions observed on gross and microscopic examination of FB-exposed pigs were 
expected and agreed with several dietary studies in the literature (10-12, 41). The pale-
yellowish surface areas as well as the mild necrosis and disorganization of hepatic cords 
observed in the livers of two of the FB-G pigs could be explained by the concentration of 
unreacted FB in their diet (122 pmol/kg). Similar microscopic lesions have been observed in 
pigs fed 24 fimol FBi/kg diet for 5 d (11) or 42 gmol FBi/kg diet for 28 d (10), both lower 
than the FB concentration in the diet of our FB-G pigs. 
In conclusion, the results of feeding dietary FB-glucose reaction products at 528 
jimol/kg diet with 23% unreacted FB (122 p.mo 1 FB/kg) suggest that these products could 
substantially protect swine in instances of widespread FB grain contamination. Additional 
research is required to explore the feasibility of this detoxification strategy in swine feed 
operations affected by FB contamination. Its implementation in the field will largely depend 
on the use of appropriated feed processing equipment. 
3.6. ABBREVIATIONS USED 
AST, aspartate aminotransferase; BIL, total bilirubin; C-20, t/,/-erythro-C20-
dihydrosphingosine; CHOL, total cholesterol; DEN, diethylnitrosamine; ELEM, equine 
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leukoencephalomalacia; FBi, fumonisin Bj; FBz, fumonisin B2; FB, fixmonisins (FB, + FB2); 
FB-G, fumonisin B-glucose; GGT, y-glutamyltransferase; NEB, non-enzymatic browning 
reaction; OPA, o-phthalaldehyde; PPE, porcine pulmonary edema; Sa, sphinganine; So, 
sphingosine; Sa/So ratio, ratio of sphinganine to sphingosine. 
3.7. SAFETY 
Fusarium moniliforme Ml325 com culture material contains fumonisin Bi, a class 2B 
carcinogen. In consequence, it was handled accordingly. 
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Legends to the figures: 
Figure 1. Weight gain comparison between pigs fed 0 (control), 528 (FB) and 528 pmol 
total FB/kg diet with 23% unreacted FB (122 pmol total FB/kg diet) (FB-G). n=6 pigs. The 
error bar represents the standard error or the mean (SEM). Different letters above error bars 
indicate statistically significant differences between the treatment groups at a given time 
point (P<0.05). Average initial body weights (D 0) did not differ significantly among the 
groups. 
Figure 2. (1) Liver from a fumonisin B-treated pig with an individual necrotic cell (a), a 
shrunken hepatocyte with condensed chromatin (apoptosis) (b), disorganized hepatic cords, 
and marked cellular pleomorphism with megalocytosis (c). (2) Liver from a pig in control 
group. Significant microscopic lesions were not observed. (3) Liver from a Fumonisin B-
glucose-treated pig. Significant microscopic lesions were not observed in four of 6 
pigs. Hematoxylin and eosin stain. Bar = 30 jj,m. 
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Table 1. Levels of aspartate aminotransferase (AST), y-glutamyl transferase (GGT) total 
bilirubin (BIL) and total cholesterol (CHOL) in serum at d 0, 5, 10 and 15 of the study (FB 
levels in diets: 528 gmol/kg in FB group, 122 gmol/kg in FB-glucose group). n=6 pigs3 
AST (IU/L) GGT (IU/L) BIL (mg/dL) CHOL (mg/dL) 
Day 0 
Control 34.83 ± 3.94 a 28.5 ± 5.46 a 1.84+ 0.48 a 257.67 ± 15.29 a 
FB 33 ± 3.96 a 31.33 ±5.23 a 1.09 ± 0.44 a,b 235.5 ±32.11 a 
FB-glucose 30.33 ±2.19 a 41.67 ±5.11 a 0.53 ± 0.19 b 293.5 ± 24.4 a 
Day 5 
Control 32.33 ± 3.77 b 30 ± 4.37 b 0.12 ±0.01 b 129 ±25.3 a 
FB 212.83+42.56 a 65.67 + 7.64 a 1.51 ±0.48 a 166.17+ 18.06 a 
FB-glucose 54.33 ± 12.33 b 50.17 ±9.43 a,b 0.11 ± 0.02 b 83.67 ± 5.87 b 
Day 10 
Control 36 ± 3.78 b 29.17 ± 4.57 b 0.08 ± 0.01 b 68 ± 3.09 b 
FB 414.33 ± 56.87 a 189 ±43.07 a 2.87 ± 0.81 a 196.17 ±40.24 a 
FB-glucose 40.83 ± 2.94 b 50 ± 7.02 b 0.06 ± 0.01 b 89.33 ± 4.36 b 
Day 15 
Control 120.17 +18.7 c 47.33 ± 10.1 c 0.11 ± 0.02 b 76.33 ± 4.26 b 
FB 576 ± 83.22 a 250.5 ± 48.06 a 3.31 ±1.2 a 204.83 ± 32.25 a 
FB-glucose 180.67 + 51.11 b 99.33 + 23.28 b 0.41 + 0.25 b 119.17 ± 29.27 b 
"The data entries in the table are expressed as mean ± SEM. Different letters indicate 
statistically significant differences between the group means at a given time point (P<0.05). 
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Table 2. Levels of sphinganine (Sa) and sphingosine (So) (nmoles/mL) and the Sa/So ratio 
in serum on d 0, 5 and 10 and 15 of the study (FB levels in diets: 528 |amol/kg in FB group, 
122 |imol/kg in FB-glucose group). n=repeated extractions8 
Sa (nmoles/mL) So (nmoles/mL) Sa/So 
Day 0 
Control 0.4 ±0.14 a* 1 ± 0.27 a 0.44 ±0.15 a 
(n=14) (n=ll) (n=10) 
FB 0.3 ± 0.15 ab* 0.75 ± 0.33 a 0.49 ±0.15 a* 
(n=16) (n=17) (n=15) 
FB-G 0.1 ± 0.02 b 0.48 ± 0.08 a 0.26 ± 0.06 a* 
(n=16) (n=16) (n=16) 
Day 5 
Control 0.12 ± 0.02 b* 0.56 ± 0.08 a 0.3 ± 0.07 b* 
(n=18) (np=17) (n=17) 
FB 0.6 ± 0.08 a 0.7 ±0.19 a 1.3 ±0.19 a 
(n=17) (n=18) (n=17) 
FB-G 0.16 ±0.02 b* 0.47 ± 0.09 a 0.52 ±0.1 b* 
(n=18) (nM8) (n=18) 
Day 10 
Control 0.09 ± 0.01 c 0.47 ± 0.16 b 0.6 ±0.15 b 
(n=17) (n=16) (n=15) 
FB 0.76 ± 0.13 a 0.61 ±0.12 a* 1.83 ±0.34 a* 
(n=18) (n=16) (n=16) 
FB-G 0.28 ± 0.09 b 0.53 ±0.15 a* 0.95 ±0.16 a* 
(n=16) (n=14) (n=10) 
Day 15 
Control 0.21 ± 0.05 c 0.53 ±0.14 a* 0.5 ± 0.08 c 
(n=T 8) (n=18) (n=16) 
FB 0.92 ± 0.06 a 0.64 ± 0.09 a* 1.78 ±0.18 a 
(n=18) (n=18) (n=18) 
FB-G 0.5 ± 0.07 b 0.78 ± 0.25 a 1.14 ± 0.2 b 
(n=18) (n=18 ) (n=16) 
"The concentration of sphingolipids is expressed as nanomoles per milliliter of serum. The 
data entries in the table are expressed as mean ± SEM. Different letters indicate statistically 
significant differences between the group means at a given time point (P<0.05). 
* Significantly different at P<0.1. 
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Table 3. Liver levels of sphinganine (Sa) and sphingosine (So) (nmoles/g) and the Sa/So 
ratio in liver on d 15 of the subacute study (FB levels in diets: 528 |imol/kg in FB group, 122 
gmol/kg in FB-glucose group). n=repeated extractions" 
Sa So Sa/So 
(nmol/g) (nmol/g) 
Control 0.3 ± 0.03 c 20.9 ± 6.4 c 0.03 ± 0.04 b 
(n=18) 0M3) (n=13) 
FB 6.2 ± 0.4 a 69.4 ± 9.9 a 0.15 ±0.03 a 
(n=18) (n=17) (n=17) 
FB-G 3.02 ± 0.4 b 48.6 ± 9.4 b 0.11 ±0.03 ab 
(n=18) (n=18) (n=18) 
aThe concentration of sphingolipids is expressed as nanomoles per gram of liver tissue. 
The data entries in the table are expressed as mean ± SEM. Different letters indicate 
statistically significant differences between the group means (P<0.05). Levels of So in the 
FB group were different from FB-G group at a 10% significance level. 
weight gain, kg 
D 
3  3 °  
4 'WLTOW 
Figure 2 
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CHAPTER 4. GENERAL CONCLUSIONS 
4.1. General Discussion 
The results from the intraperitoneal and dietary studies presented in this dissertation 
clearly demonstrated that the FB-glucose reaction products administered by any of these two 
routes of exposure are effective at detoxifying FB in swine, one of the most sensitive animal 
species to this mycotoxin. These products were obtained by chemically reacting the primary 
amine groups of purified FBi, or FB from F. verticillioides culture material, with reducing 
sugars (i.e. glucose) through the non-enzymatic browning reaction (/), a common reaction in 
foods. 
In general, both studies showed an increase in body weight gain in pigs exposed to 
FB-glucose products when compared to animals exposed to FB alone. It is noteworthy that 
the increase in body weight was less dramatic in the pigs exposed to FB-glucose products in 
the intraperitoneal study. The cause of this phenomenon remains unknown, although stress-
related events could have played a role. In addition, a dramatic reduction in levels of serum 
chemistry parameters indicative of FB-induced liver injury, such as the liver enzymes AST 
and GGT, total bilirubin, and total cholesterol; was observed in pigs exposed to FB-glucose 
products as compared to animals exposed to FB alone. Interestingly, the liver total 
cholesterol levels of FB-glucose pigs in the dietary study matched their serum total 
cholesterol levels, and were lower than in their FB counterparts. This suggested a 
relationship between the inhibition of the enzyme ceramide synthase in the de novo 
sphingolipid synthesis pathway and the synthesis of cholesterol in the liver of FB-exposed 
pigs (2-4). Significant reductions in serum and liver concentrations of the sphingoid base 
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sphinganine, which generally increases in cases of FB exposure as a result of the inhibition of 
the enzyme ceramide synthase, were observed in FB-glucose-exposed pigs in both studies. 
In consequence, an important reduction in the Sa/So ratio in serum and liver, a widely 
accepted biomarker of exposure to FB, was also detected in pigs exposed to FB-glucose 
products in both studies. Interestingly, the serum and liver levels of sphinganine and the 
Sa/So ratio in pigs exposed to the FB-glucose products in the dietary study, although still 
significantly lower than in pigs exposed to FB alone, were higher than in the control pigs. 
This suggested a possible weak inhibition of the enzyme ceramide synthase in these animals 
by the FB-glucose products or by the remaining free FB in their diets that is worth exploring. 
Gross pathology evaluation of FB-exposed pigs showed jaundice of the liver and surrounding 
tissues, a lesion characteristic of liver damage. No obvious lesions could be found in pigs 
exposed to FB-glucose products. Microscopic evaluation of liver and kidney tissues in FB-
exposed pigs revealed lesions typically induced by FB such as individualized hepatocyte 
necrosis and apoptosis, whereas no significant lesions were found in animals exposed to FB-
glucose products. These results conclusively show the efficacy of the FB-glucose products in 
dramatically reducing the toxic effects of FB in pigs, a species of significant agricultural 
importance in the United States and worldwide. 
The experimental evidence presented in this dissertation adds to the already known 
beneficial FB-detoxifying properties of the FB-reducing sugar reaction products. Evidence 
of their efficacy had been previously presented for rats and mice, not only using glucose as 
the reducing sugar but also fructose (5, 6). Both sugars can be found in fairly high levels in 
food materials commonly used worldwide in the food industry such as corn syrup, which 
makes this detoxification strategy even more feasible for use by swine farmers, the food 
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industry or any individual potentially being exposed to high levels of FB in foods. It is 
important to notice that the benefits derived from the findings presented in this work will 
greatly depend on the availability of an affordable, food-processing piece of equipment in 
which FB-contaminated foods could be reacted with a reducing sugar (i.e. glucose) under 
high temperature. Extrusion, a technology commonly employed in the food industry to 
process corn grain at high temperature and pressure with water present (7, 8), would be an 
excellent starting point in the design of the FB-glucose reaction processing equipment 
mentioned here. 
If such a piece of equipment is readily accessible, the benefits from this detoxification 
strategy could be great and possibly extend to humans. Individuals exposed to high levels of 
FB in their diets, mostly in developing countries such as South Africa, China, Yugoslavia, 
Guatemala, Mexico, etc.; could treat the FB-contaminated corn-based foods with glucose and 
hence be able to decrease dramatically the potential toxic effects of the mycotoxin. This 
could have an important effect in lowering the incidence of FB-related health problems such 
as esophageal cancer, a disease that according to the World Health Organization (9) accounts 
for 410,000 new cancer cases worldwide each year. 
4.2. Recommendations for Future Research 
Additional research in this area should concentrate in five objectives: 
1. To develop a process for large-scale conversion of FB to FB-glucose in swine 
production units. As mentioned earlier in this chapter, this process could be potentially 
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adapted to treat human corn-based foods contaminated with FB and lower the concentration 
of the mycotoxin. 
2. To determine if one or more of the FB-glucose reaction products, obtained when 
FB is chemically reacted with glucose, may inhibit the enzyme ceramide synthase in the de 
novo sphingolipid synthesis pathway. Some of the FB-glucose reaction products may still 
resemble the chemical structure of the sphingoid bases and be able to bind the enzyme. 
Collaboration with other scientists in the sphingolipids area have already been set to 
determine the toxicity of individual purified FBi-glucose reaction products in cultured cells. 
3. To understand the possible relationship between the elevation of sphingoid bases 
and subsequent decrease in major sphingolipids (i.e. sphingomyelin) in animals exposed to 
FB, and the elevation in levels of cholesterol esters in the liver. Learning about this 
relationship could help better understand the complex consequences of the FB-induced 
alterations in sphingolipid metabolism. 
4. To explore the use of the FB-glucose reaction products in detoxifying FB in 
horses. Horses are the most sensitive known animal species to FB, where it causes 
neurotoxicity. Due to the obvious economical and physical limitations of working with 
horses, rabbits have been proposed as a potential FB-induced neurotoxicity model since 
previous studies have found lesions of FB-induced leukoencephalomalacia in this species. 
5. To explore the use of the FB-glucose reaction products in preventing the 
occurrence of neural tube defects in fetuses of species sensitive to FB. Mice models that are 
already available could be modified to include FB-glucose reaction products in the treatment 
diets. Results of these investigations could be important to prevent this birth defect in human 
populations of vulnerable geographical areas such as the Mexican-US border. 
158 
6. To explore the causes of the variability among pigs on their susceptibility to FB. 
In the case of IV or IP exposure, this variability may be product of a genetic polymorphism 
of the enzyme ceramide synthase in pigs. In addition to genetic causes, in the case of dietary 
exposure, different susceptibilities might be explained by differences in gastrointestinal 
absorption of FB among pigs, which would affect FB bioavailability and ultimately the 
severity of its toxic effects in this species. 
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APPENDIX. ADDITIONAL TABLES 
Table 1. Feed consumption (g) on days 1, 4 and 7 of the intraperitoneal subacute FB,-
glucose study in swine (FB, dosage: 5.5 (imol/kg BW; free FB, in FB,-glucose dosage: 0.6 
fimol/kg BW). n=4 pigs" 
Day 1 Day 4 Day 7 
Control 173.3 ± 41.6 a 253.5 ± 21.3 a 302.5 ± 37 a 
FB, 158.5 ±34.3 a 40.5 ±24.2 b 0±0bb 
FBi-G 66 ±45.8 a 139.5 ±84.2 ab 197 ±90.7 a 
"Data is expressed as average grams of feed consumed by treatment groups at a given time 
point. P<0.05. 
TData from day 6 of the study. 
Table 2. Feed consumption (g) on days 1,5, 10 and 15 of the dietary total FB-glucose study 
in swine (FB levels in diets: 528 fimol/kg in FB group, 122 jimol/kg in FB-glucose group). 
n=6 pigs3 
Control 
FB 
FB-G 
Day 1 
177.5 ±40.1 a 
210.3 ± 43.4 ab 
308.5 ±39.1 be 
Day 5 
417.8 ±70.3 a 
241.7 ± 48.8 b 
413.8 ± 28.7 c 
Day 10 
543.8 ±76.1 ab 
329.3 ± 46.4 a 
810.5 ± 66.1 be 
Day 15 
819.2 ±71 a 
376.2 ± 100.4 b 
813.5 ± 141.3 a 
"Data is expressed as average grams of feed consumed by treatment groups at a given time 
point. P<0.05. 
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Table 3. Feed consumption (g) as a percentage (%) of body weight on days 1,5, 10 and 15 
of the dietary total FB-glucose study in swine (FB levels in diets: 528 |imol/kg in FB group, 
122 ^mol/kg in FB-glucose group). n=6 pigs3 
Control 
FB 
FB-G 
Day 1 
3 ± 0.7 a 
3.2 ± 0.7 ab 
4.7 ± 0.6 b 
Day 5 
6.2 ± 0.9 a 
3.5 ± 0.7 b 
5.3 ± 0.4 a 
Day 10 
6.8 ±1.1 abb 
4.2 ± 0.5 a 
8.2 ± 0.7 bb 
Day 15 
8.1 ± 0.5 a 
4.4 ± 0.8 b 
6.8 ± 0.9 a 
"Data is expressed as average grams of feed consumed by treatment groups at a given time 
point. P<0.05. 
Significantly different at P<0.1. 
Table 4. Organ to body weight ratios in the intraperitoneal subacute FBi-glucose study in 
swine (FBi dosage: 5.5 pmol/kg BW; free FB] in FBi-glucose dosage: 0.6 |imol/kg BW). 
n=4 pigs" 
Ratio Lungs Liver Kidneys Heart 
organ/body 
weight 
Control 
FB, 
FBT-G 
0.011 a 
0.017 a 
0.013 a 
0.029 a 
0.028 a 
0.026 a 
0.006 a 
0.007 a 
0.006 a 
0.008 a 
0.009 a 
0.008 a 
"Ratios of lungs, heart, liver of kidneys to body weight were not different between the 
treatment groups (P<0.05). 
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Table 5. Organ to body weight ratios in the dietary total FB-glucose study in swine (FB 
levels in diets: 528 pmol/kg in FB group, 122 gmol/kg in FB-glucose group). n=6 pigs3 
Ratio organ/body Heart Liver Kidneys 
weight 
Control 0.006 a 0.026 a 0.006 a 
FB 0.006 a 0.025 a 0.007 a 
FB-G 0.006 a 0.026 a 0.006 a 
"Ratios of heart, liver of kidneys to body weight were not different between the treatment 
groups (P<0.05). 
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